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Abstract
Porosity, pore size and pore interconnectivity have been shown to be critical factors for
cellular infiltration into vascular grafts. While electrospinning has been shown to produce
many promising characteristics for the fabrication of vascular graft scaffolds, it has yet
to create sufficient porosity for transmural endothelial in-growth. This study was aimed
at using dual electrospinning with sacrificial fibre extraction to produce scaffolds with
controllable porosity characteristics while maintaining sufficient structural strength to
resist deformation during implantation. Scaffolds were subsequently covalently grafted
with heparin, a known anti-coagulant with growth-factor binding properties.
Poly(ethylene oxide) (PEO) and Pellethane R© (PU) were spun simultaneously and sub-
sequently PEO was selectively extracted to create additional void space within the fi-
brous structure. Low, medium and high porosity scaffolds (76%±0.2%, 83%±0.5% and
90%±1.0% respectively) along with their heparinized versions were analysed in vitro for
pore size, porosity, fibre morphology and mechanical properties; and in vivo for cellu-
lar infiltration, vascularisation, collagen deposition and inflammation subcutaneously in
male Wistar rats (7,14 and 28 days, n = 6).
The tensile strength (σt = −44P + 41 MPa, r2=0.96) and elastic modulus (E = −9.2P +
9.0 MPa, r2=0.97) of the constructs decreased linearly with increasing porosity (P ) (post
PEO removal) and the heparinization process resulted in decreased strength (8.4±4.9MPa
to 2.2±1.1 MPa, p<0.02) but slightly increased stiffness (9.0±0.6 MPa to 9.7±1.2 MPa,
p<0.001) when compared to non-heparinized scaffolds (100% PU). Calculated compliance
values increased with increases in sacrificial fibre fraction (Cd[PU ] = −0.078FFPU + 10.3
%/100mmHg, r2 = 0.72, p<0.001 and Cd[PU+Hep] = −0.038FFPU + 6.93 %/100mmHg, r2
= 0.45, p<0.05) and closely matched the compliance values of the human popliteal artery
reported in literature. Average pore-size for low, medium and high porosity scaffolds
was 4.0±2.3µm, 9.9±4.2µm and 11.1±5.5µm (p<0.0001). Heparinization resulted in
increased fibre diameter (3.6±1.1µm vs 1.8±0.8µm, p<0.0001) but did not influence
pore-size (p>0.66).
Cellular infiltration for low, medium and high porosity scaffolds reached 33±7%, 77±20%
and 98±1% of scaffold width respectively by day 28 of implantation (p<0001); hepariniza-
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tion did not influence infiltration.
Electrospun grafts with selectively extracted sacrificial fibres allowed for tunable poros-
ity and pore-size. Increasing porosity resulted both in predictable losses to mechanical
strength and improvements to cellular infiltration which could prove to be a useful op-
timization parameter for vascular grafts. This method of electrospinning shows great
promise for fabrication of synthetic vascular graft substitutes, for the purpose of produc-
ing spontaneous transmural endothelialisation, and warrants further study in a circulatory
model.
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Glossary
Ex Vivo Testing in tissue that has been excised from a living organism.
In Vitro ”In Glass”, Testing physiological phenomena outside of the physiological con-
text.
In Vivo Testing inside a living organism.
Abluminal The outer surface of a hollow organ.
Allograft Vessel transplanted between different individuals of the same species.
Anastomosis Surgical union of two hollow organs, synthetic or biological..
Anisotropy A property of being directionally dependant.
Atherosclerosis Plaque deposition in the luminal surface of blood vessels causing vessel hard-
ening and constricted blood flow.
Autograft Vessel harvested from patients own body for transplant at a different site.
Biodegradable The ability of a material to degrade under physiological conditions whether
hydrolytically or enzymatically.
Dielectric Constant A measure of the permittivity of a material expressed as a ratio relative to
the permittivity of a vacuum.
Endothelium A layer of epithelial-like cells lining the luminal surface of certain organ cav-
ities, such as blood vessels.
Fibre Fraction The ratio of structural fibres mass to total mass of the scaffold (including
sacrificial fibres).
Gauge Length The length of a specimen at no load conditions before being subjected to
tensile strain.
Graft A replacement for a blood vessel either biological or synthetic.
Hyperplasia Abnormal growth caused by excessive proliferation of cells.
Luminal The inside surface of a hollow organ.
Lyophilization A dehydration process which dries frozen samples by process of sublimation
under near-vacuum pressures.
Neovascularisation Formation of functional microvascular networks.
Patency Rate The percentage of grafts still patent after a given time period.
Patent Refers to blood vessels that remain open and unblocked.
Permittivity A measure of a materials resistance to an applied electric field.
Porogen A particle used for creating pores within another substance / material / con-
struct.
Proliferation Dividing of a mother cell into two daughter cells.
Sacrificial Fibre Refers to the group of fibres present in the scaffold which are removed to
generate voids between structural fibre groups.
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Structural Fibre Refers to the group of fibres present in the scaffold which form the remaining
architecture after sacrificial the fibre group’s removal.
Thick Groups Scaffolds where PEO fibres were spun using DCM as a solvent to produce
thick sacrificial fibres.
Thin Groups Scaffolds where PEO fibres were spun using EtOH as a solvent to produce
thin sacrificial fibres.
Thrombosis Formation of a thrombus.
Thrombus A blood clot acting to partially or completely block a blood vessel.
Transanastomotic Refers to events occurring over the anastomosis of the graft.
Transmural Refers to events occurring through the wall of the graft.
Xenograft Vessel transplanted between different species.
Glossary xiii









AIDS Acquired Immune Deficiency Syndrome.
BPM Beats Per Minute.
CAD Computer-Aided Design.
CCA Common Carotid Artery.
CD Circumferential Direction.








EGV Inferior Epigastric Vein.
ePTFE Expanded Polytetrafluoroethlene.




FFA Fluoroscein Free Acid.
FLA Femptosecond Laser Ablation.
FLUF Focused, Low density, Uncompressed nanoFibre.
FR Flow Rate.
GL Gauge Length.
H&E Hemotoxylin and Eosin.
HDF Human Dermal Fibroblast.
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Hep Heparin surface modified.
hFOB Human Fetal Osteoblasts.
hMSC Human Mesenchymal Stem Cells.
HP High Porosity.
HUVEC Human Umbilical Endothelial Cell.
HVPS High Voltage Power Supply.
HVSC Human Vena Saphena Cell.
IND Inter-Nodal Distance.
LP Low Porosity.
LTE Low Temperature Electrospinning.











PAD Peripheral Artery Disease.
PAN Polyacrylonitrile.
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SD Standard Deviation.
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Nomenclature
Cd Diametral Compliance.
Dd Inner Diameter at Diastolic Pressure.
di Inner Diameter.
do Outer Diameter.
Ds Inner Diameter at Systolic Pressure.




Q Volume Flow Rate.
η Efficiency Factor.
FFPU Polyurethane Fibre Fraction.
kg Kilogram.
m Mass.
mafter Mass of scaffold after sacrificial fibre removal.






MPa Mega Pascal (N/mm2).
mPEO Mass of polyethylene oxide present in the scaffold.
mPU Mass of polyurethane present in the scaffold.
P Porosity.
P d Diastolic Pressure.
P i Luminal Pressure.




RPM Revolutions per Minute.
σh Hoop Stress.
xvii
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σt Tensile Stress.
tsystole Systolic Period.
V a Volume after sacrificial fibre removal.
V b Volume before sacrificial fibre removal.
V f Fibre Volume.
ws Scaffold Width.
Nomenclature xviii




Atherosclerosis is the leading cause of death worldwide, causing nearly three quarters of all
cardiovascular diseases [1]. Presently the most effective method of treating atherosclerosis
is by surgical intervention whereby the afflicted artery is bypassed with a graft. There are
three main categories under which vascular grafts can be divided: large calibre grafts with
luminal diameters of 8mm or greater; medium calibre grafts with corresponding diameters
between 6 and 8mm and small calibre grafts with diameters less than 6mm [2,3].
For large calibre bypasses, synthetic grafts have been largely successful with the use of
expanded Polytetrafluoroethlene (ePTFE) and Dacron R© (PET, Poly(Ethylene Teraph-
thelate)) as graft materials. These same materials have had moderate success in medium
calibre applications. However, all synthetic choices have failed dismally in the small cal-
ibre arena where the autograft remains the gold standard. The latter, however, is not
always available or suitable for use which excludes surgical intervention, reducing life
quality and expectancy [4]. This is disconcerting considering that the requirement for
small and medium diameter grafts is much greater than for large diameter grafts. In the
USA a 1999 study on clinical procedures involving vascular grafts showed that 71% con-
sisted of small diameter vessels, 24% fitting in-between the small and medium diameter
classification and only 5% required large diameter vessels [5, 6].
Considering that all coronary and lower extremity peripheral artery bypasses fall into the
small to medium calibre classification it is important to note the following statistics:
1. An estimated 6.4% of United States (US) adults over the age of 20 have some form
of coronary heart disease (CHD).
2. 2.9% of US adults have had CHD resulting in myocardial infarction.
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3. CHD accounted for almost 1 in every 6 deaths in the US. [7]
4. Prevalence of peripheral arterial disease (PAD) is 10%-25% (age >55 years). [8]
5. Patients with PAD are at the same relative risk of death, from cardiovascular causes,
as those with CHD or cerebrovascular disease. [8–11]
In South Africa 195 people died per day from some form of cardiovascular disease between
1997 and 2004. This statistic was projected to increase by 41% between 2000 and 2030
despite the overwhelming death rate caused by AIDS [12]. A separate study on rural
black South Africans determined that PAD prevalence in the population (542 patients)
was significantly higher than global averages [11]. Given these morbid statistics it can
be seen that a readily available, small diameter, off-the-shelf prosthetic graft with a
satisfactory patency rate would be a welcome addition to the arsenal of tools in the fight
against PAD and CHD.
In terms of treatment, a patient has three different options depending on the extent of
atherosclerosis present in the artery and the stability of the patient [13]. Pharmacological
therapy and risk factor modification is a first choice to patients who have stable, minor le-
sions. If pharmacological therapy is ineffective then minimally-invasive procedures such as
balloon angioplasty, stenting, rotoblation and cutting balloons can be performed. These
procedures are minimally invasive due to the use of catheters but require specialized
equipment, a great deal of expertise and are not without their risks. As a last resort
bypass surgery is performed where grafts are used to bypass the blocked artery. These
surgeries are highly invasive with long recovery periods but in many cases are the only
option either due to arteries that are beyond repair or inaccessible by the other two
treatment options.
As mentioned earlier the autologous graft is not always available or suitable, requires
extra surgical time, more patient discomfort postoperatively and donor site morbidity.
If a synthetic alternative to the autologous graft could be developed; not only will all
patients benefit from not requiring a donor vein/artery but the unfortunate few who do
not have an appropriate donor vessel will have, for a first time, a viable alternative.
The primary reasons for failure of small calibre synthetic grafts are thrombosis and intimal
hyperplasia (which will be discussed in detail in Section 2.1.4). Essentially both failure
modes can be attributed to a combination of compliance mismatch and lack of healthy
endothelial cell lining the luminal surface of the graft [14]. The latter of which is believed
to be caused by insufficient porosity, pore size and pore-interconnectivity for spontaneous
transmural endothelialisation to occur [3, 15,16].
Currently there is much work being done to solve the patency issues of small diameter
vascular grafts. The two main streams of focus at present are tissue engineering and
Chapter 1: Introduction 2
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regenerative medicine. Tissue engineering involves seeding cells in vitro onto a tubular
scaffold and allowing them to grow into engineered blood vessels that are then implanted
as grafts [17]. This method is very labour intensive, expensive, requires specially designed
facilities and requires each graft to be matched to a patient by using autologous cells [18].
In contrast regenerative medicine techniques involve implanting an engineered scaffold
into the patient and allowing the patient’s body to populate the graft with cells. For
example, the Wang group have developed grafts which rapidly degrade in vivo to make
space for cells to grow in its place while still providing cells with chemical and mechanical
signals to guide cell differentiation into appropriate tissue [19, 20]. This work, while
promising, still requires much optimization before clinical application, part of which is
improved porosity to allow for spontaneous transmural endothelialisation.
1.2 Aims of Current Study
In the current study, the regenerative medicine approach is proposed. Current research
points to porosity, pore size and pore interconnectivity as being key success factors in
creating grafts with long-term patency [2, 3]. Pennel et al (2013) demonstrated that
transmural endothelialisation was possible with high-porosity (pore diameter ≈ 150µm)
grafts made of foamed polyurethane produced by a phase inversion/porogen extraction
technique [16,21].
This project was aimed at developing a method for creating electrospun (electrospinning
is described in detail in Section 2.2) fibrous scaffolds of controllable porosity and mechan-
ical properties and then subsequently modifying the surface chemistry of the polymer for
more favourable regenerative outcomes. In order to achieve this goal a two-step fabri-
cation process was designed: firstly dual electrospinning with sacrificial fibres, where a
water soluble fibre was included and subsequently removed from the scaffold was em-
ployed; followed by surface immobilization with heparin, a known anti-coagulant and
anti-thrombotic with growth factor binding properties.
The removal of the sacrificial fibres was expected to increase the void space between
the remaining structural fibres making it possible to control porosity depending on the
percentage volume of each fibre type incorporated into the scaffold, as has been shown
previously by Baker et al (2008). However, this study differed from Baker’s in that it
utilized flow rate as a method of controlling fibre fraction rather than number of spinnerets
or spinneret offset, and additionally investigated the effects of sacrificial fibre diameter
on scaffold porosity (post sacrificial fibre removal).
It was hypothesized that high porosity scaffolds, with large interconnected pores would
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exhibit improved cellular infiltration over low porosity scaffolds.
The results of this thesis would provide information on whether this method has promise
for demonstrating spontaneous transmural endothelialisation in a circulatory model.
Objectives The objectives of this thesis were to (See Figure 1.1):
1. Modify and upgrade the existing electrospinning equipment to allow for dual-
spinning.
2. Develop the dual electrospinning method to accommodate the fabrication of small
diameter vascular grafts.
3. Optimise the spinning of PEO to produce either thin or thick fibres.
4. Show scaffold porosity and pore size increase with increasing PEO fibre weight
percentage (fibre fraction).
5. Determine effects of sacrificial fibre diameter on porosity, pore size and mechanical
properties.
6. Immobilize heparin on the surface of the scaffold structural fibres.
7. Determine effects of heparinization on porosity, pore size and mechanical properties.
8. Determine effects of porosity and pore size on cellular ingrowth and healing response
in vivo (rat subcutaneous model).
9. Determine effects of heparinization on cellular ingrowth and healing response in
vivo.
Chapter 1: Introduction 4
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Figure 1.1: Graphical abstract of project objectives: Effectiveness of inclusion and subse-
quent removal of thin versus thick sacrificial fibres was assessed and compared. The most
effective method was then used to create low, medium and high porosity scaffolds which
were then heparinized and assessed for porosity, pore size and mechanical properties be-
fore being implanted in vivo in a rat subcutaneous model to assess healing response. (Rat
cartoon adapted from [22])
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2.1.1 Brief History of Vascular Grafts
The first recorded vascular surgery repair occurred in 1759 when Hallowell and Lambert
repaired a brachial artery with a suture. More than a century later the first vascular
anastomosis was successfully performed on a canine model by Nicholai Eck in Pavlov’s
laboratory. Robert Abbe documented the first prosthetic graft implant in 1894 by plac-
ing hour-glass shaped tubes in the proximal and distal lumens of a feline aorta. The
glass tubes were then enclosed in silk and sutured to the vessels on either side of the
tube. [23].The study of vascular repair then accelerated in the early 20th century result-
ing in numerous breakthroughs with arguably the most prevalent being the first autograft
procedure by Goyannes in 1906 with the repair of a popliteal artery aneurysm by trans-
planting it with a harvested popliteal vein from the same patient. [2]
Almost half a century later, in 1952, Voorhees created prosthetic grafts from a material
named Vinyon ”N” cloth, first documenting the importance of porosity in vascular grafts
[24]; he used this material as a bypass graft for the abdominal aorta in 15 canine models
with a relatively high success rate [24] which led to the materials use 2 years later in the
surgical treatment of aneurysms of the abdominal aorta in humans [25].
The next 60 years would see polyethylene terephtalate (PET, Dacron R©) and expanded
polytetrafluoroethylene (ePTFE) grafts forming the gold standard for large calibre vas-
cular prosthesis, while the autograft remains the gold standard for small and medium
calibre bypass grafts to this day [2, 26].
6
University of Cape Town Department of Biomedical Engineering
2.1.2 Types of Grafts
Principally there are two different graft types available: Biological or synthetic. The
former referring to the use of veins or arteries harvested from autologous, homogeneous
or xenogeneic sources. Both synthetic and biological grafts can be modified further, either
chemically for in vivo regeneration of native tissue or tissue engineered with a patients’
own cells in vitro to improve healing outcomes [5, 27]. The subsections to follow will go
into more detail on each type.
2.1.2.1 Biological Grafts
Autografts are veins or arteries extracted from elsewhere in the patients own body.
In vascular replacement surgery of small and medium sized grafts the autologous vessel
remains the gold standard to this day.
In the case of a coronary artery bypass the vessels of choice are the internal mammary ar-
teries (left and right), greater saphenous vein (SVG), radial artery and the gastroepiploic
artery [5, 28]. However, the surgeons decision on which vessel to use as a graft is not as
simple as going down a list, there are many factors that need to be taken into consider-
ation such as diseased vessel position; graft length requirements; calibre and compliance
matching between vessel and graft; age and mobility of the patient and consideration for
donor site morbidity [26,28,29].
Peripheral or lower limb bypasses regularly utilise the SVG as a first choice which can
either be removed completely and reconnected as a bypass by reversing the direction of
the vein (ex vivo), or by anastomosing the SVG to the required sites on the target artery
while leaving the SVG in place (in situ). In situ bypasses require that the internal valves
be removed to allow reverse direction flow but the advantage is that the vasa vasorum
remain intact [2, 5, 30].
The desirability of autografts lie in their inherent immuno-compatibility and preservation
of at least a proportion of their endothelial lining (surgical procedures are known to cause
damage to the endothelial lining, especially in the case of SVGs [31,32]). However, it has
been noted that autologous grafts are also susceptible to occlusion despite their superior
biological composition [33].
Even though the autograft remains the dominant clinical solution in small to medium
sized vessels, they exhibit various disadvantages that are not easily addressed [2] [5]:
• The donor vessel is not always available or suited for transplant.
• The associated donor site morbidity.
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• Venous substitutes are not always capable of handling the hemodynamic forces
associated with arterial circulation.
• The increased surgical time required to extract the donor vessels.
Allografts (Homografts) refer to the use of donor vessels from the same species but
from a different individual. These types of grafts have been largely abandoned due to
the practicalities of storage and/or sourcing the donor vessels. Fresh vessels placed in
cold storage or cryopreserved vessels extracted from cadavers were used before synthetic
grafts were accepted as a more viable option for large type grafts.
The biocompatibility of allografts is not always preserved as in autografts and the healing
response of the grafts resembles atherosclerosis which leads to low patency rates over the
long term [5].
Xenografts (Heterologous grafts) are grafts made from similar vessels extracted from
a different species. Similar to allografts, xenografts (in their cellularised state) have been
widely abandoned after the development of viable synthetic alternatives due to infection,
antigenicity and storage concerns as well as a high incidence of thrombosis [34–36].
However, decellularised xenogenic tissues are still researched as scaffolds for tissue engi-
neered vessels either in their decellularised form or after in vitro tissue culture [37–40].
While these constructs have shown promising results in animal models for large and
medium calibre vessels, occlusion, intimal hyperplasia and incomplete endothelial cover-
age are observed for small calibre vessel [39–43].
2.1.2.2 Synthetic Grafts
PET (polyethylene terephthalate of the polyster family) also known by the trade-name
Dacron R©, was first patented in 1950. It is formed into fibres which are bundled into yarns
that are either woven or knitted to form grafts.
The biomechanical properties of Dacron grafts depend on how the yarns are assembled,
they can either be woven in an over-under fashion in a criss-cross structure or knitted
by looping the filament bundles around one-another (see Figure 2.1). Woven Dacron is
stiffer, stronger, less porous and resists kinking more than its knitted counter part [3].
Knitted Dacron exhibits anisotropic behaviour and its bio-mechanical properties will
change depending on whether the wound filaments (yarns) are knitted circumferentially
(weft-knit) or longitudinally (warp-knit). Weft-knit grafts were reported to dilate and
unravel and so research moved to focus on warp-knit type grafts [2]. Warp-knit type grafts
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exhibit greater porosity and compliance than woven Dacron grafts while still retaining
sufficient strength to resist bursting and facilitate suturing [5].
Dacron grafts are a surgeon’s first choice for the replacement of large diameter blood
vessels with proven clinical performance and data indicating patency rates as high as
93% after 10 years [44]. However, this performance has not been transferred to small
diameter (<6mm) vascular grafts where occlusion is frequent, with patency rates as low
as 50% after 5 years [3, 45,46].
(a) Woven Dacron (b) Knitted Dacron
Figure 2.1: Scanning electron microscopy of (a) woven dacron and (b) knitted dacron. In
general knitted dacron has greater porosity with larger pore sizes than woven dacron. [47]
ePTFE (expanded polytetrafluoroethylene) was patented by Wilbert L. Gore as Gore-
Tex R© in 1969 [2]. It is produced by a ram extrusion process to form a structure consisting
of nodes and interconnecting fibrils. ePTFE became popular due to its inert biochemical
properties and is the second choice for medium sized vascular replacements (when an
autograft is unavailable). ePTFE grafts are preferred over Dacron grafts in peripheral
bypass surgeries, and are the most frequently utilized synthetic grafts for the operation,
however, evidence for this preferential treatment is unfounded as numerous studies have
shown no statistical patency differences between the two graft types when used in this
application in humans [45,48–52].
ePTFE grafts exhibit poor patency rates when used in small calibres (±50% at 5 years
[5,53]), where it is thought that the insufficient porosity (preventing transmural endothe-
lialization [3,16]) and compliance lead to thrombosis and intimal hyperplasia, resulting in
occlusion [43,48,54]. The porosity of ePTFE is conventionally defined by the inter-nodal
distance (IND), however, the practical porosity is far less than the stated IND value due
to the tightly packed fibrils between nodes, see Figure 2.2 [3].
Polyurethane (PU) grafts are generally made from segmented thermoplastic elas-
tomers which have been specifically developed for medical applications to be tough,
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Figure 2.2: Scanning electron microscopy of ePTFE. The nodular structure with the
associated internodal distance is depicted in this figure. It can be seen that the quoted
IND is not a true representative of porosity due to the interference caused by the fibres
crossing between the nodes. [47]
compliant, fatigue resistant and have good biocompatibility and manufacturability prop-
erties [5, 55, 56]. Thermoplastic PUs are block copolymers consisting of hard segments
(providing stiffness and rigidity) and soft segments (providing flexibility) which can be
varied to adjust the mechanical properties of the bulk material [55, 56]. PU can be syn-
thesised to be either degradable (e.g. Degrapol R©) or non-degradable (e.g. Pellethane R©,
Bionate R©, Carbosil R©) under physiological conditions depending on the polymer used in
the soft domain [57]. The advantages of PU grafts, over traditional synthetics, are their
elasticity, which better match the compliance of natural vessels than stiffer, crystalline
ePTFE and Dacron grafts [58,59].
Porous PU grafts are typically grouped into two morphological classes: foamed and fib-
rillar. The former can be produced by replamineform [60], thermal inversion [61], blow-
ing/reticulation [62], gas expansion [63] and phase inversion techniques [15,21] which typ-
ically posses larger pore sizes than their fibrillar counter-parts [3,5,15]. The later can be
manufactured by knitting [64] or weaving [65] (similar to Dacron), electrospinning [66–71]
and winding [72, 73]; benefiting from high surface area per unit volume, anisotropic me-
chanical properties similar to native vessels [71] and good cellular adhesion properties (for
small diameter fibrillar structures) [74–76]. However, the disadvantage of most fibrillar
type grafts is their inherently tightly packed structure which is often impenetrable to
transmural cellular infiltration [3].
Despite their success at producing in situ endothelialisation in pre-clinical research [16,
66, 77], PU grafts have not yet received wide acceptance in the clinical setting de-
spite advantages in manufacturability and superior compliance properties to ePTFE and
Dacron [78,79]. This lack of acceptance is mainly due to in vivo degradation observed in
clinical trials of first generation PUs caused by spontaneous degradation of their polyether
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or polyester diol soft segments [2, 56, 80]. However, modern PUs are carbonate and/or
siloxane based, containing no ester/ether soft segments and have been shown to be far
more stable in vivo [56, 81,82].
Some early commercial attempts at polyurethane peripheral bypass grafts include the
Corvita R© (Corvita Corp., Miami, FL), Thoratec R© (Thoratec Lab Corp., Berkeley, CA)
and Pulse-Tec R© (Newtec Vascular Products Ltd., Clwyd, UK). The Corvita graft con-
sisted of a helically wound poly(carbonate urethane) (PCU, specifically Corethane R©)
graft with an external PET mesh for reinforcement and showed improved patency af-
ter 6 months (100%, canine abdominal aorta model) when compared to ePTFE controls
(50%) [83]; however, Georg et al (2014) reported severe biodegradation of the PCU liner
after 13 years of implant in the abdominal aortic position in a 75 year old man [84]. The
Thoratec vascular graft, originally designed as a vascular access graft (Vectra R©), consisted
of poly(ether urethane urea) and was produced by a multilayer casting technique following
reinforcement by wrapping a polyester monofilament at varying pitches [79]; however a 6
month implantation in dogs showed extensive material degradation and a high degree of
thrombus formation which aided in impeding transmural tissue ingrowth [85]. Pulse-Tec
grafts are produced by a low-temperature phase separation technique out of poly(ether
urethane) to produce large, irregular pores (u 28µm) within the bulk volume of the ma-
terial but possessed a low porosity skin on both its luminal and abluminal surfaces [79].
These low porosity skins have been shown to deter tissue ingrowth and the poly(ether
urethane) material exhibited significant degradation after 6 months of implantation in a
canine model [85].
More modern PU grafts include Myolink R©, a poly(carbonate-urea)urethane vascular graft
which has been shown to be mechanically stable after 36 months of implantation (beagle
dogs) [58], and UCL-NANO
TM
, a nanocomposite polymer of polycarbonate urea-urethane
incorporated with polyhedral oligomeric silsesquioxane (POSS) nanocages [86,87].
Another issue needing to be addressed with non-degradable vascular grafts is mineral-
isation (calcification). The degree of calcification has been shown to be more strongly
correlated with soluble calcium levels and device function (e.g. high rates of cyclic de-
formation associated with heart valves) than polymer chemical composition [88]. While
synthetic vascular grafts have also been shown to be susceptible to calcification [88], where
deformation is more moderate than in heart valve applications, ePTFE has been shown
to be significantly more prone to calcification than PU in vitro [89]. Slow degradable
materials such as PCL have also been shown to exhibit calcification in long term vascular
graft (18 months, rat abdominal aorta) studies [90].
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2.1.2.3 Preferences per Vessel Calibre
Each type of graft has met with varying degrees of success depending on the vascular
region where it is applied, which are summarised in Table 2.1:

































2.1.3 Requirements of a Prosthetic Graft
The task of a prosthetic graft is very simple, ”form a vessel in which blood can be trans-
ported from one end to the other without leaks nor blockage”. However, the environment
in which it must accomplish this simple task makes it far more complex. The physiolog-
ical environment is highly active with inter-dependencies between the cellular structure
of the vessel wall and the biochemical environment of the lumen.
When all factors are considered a more exhaustive list of properties / characteristics that
the ideal vascular graft should possess are [2, 34,56,91]:
1. Mechanical Strength






8. Ease of surgical handling
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9. Thrombosis resistance in vivo
10. Infection resistance
11. Haemostasis between graft and surrounding tissue
12. Ability to grow in vivo if required
13. Easy sterilization
2.1.4 Reasons for Failure of Small Diameter Vascular Grafts
With over 60 years of development in the field of vascular grafts, researchers have iden-
tified what is thought to be the root causes of the failure observed in small diameter
synthetic grafts. The two major causes of failure being midgraft thrombosis and intimal
hyperplasia are described below [92].
Midgraft Thrombosis: The endothelial cells lining the inner wall of blood vessels per-
form crucial functions in maintaining haemostasis. Synthetic grafts are typically without
an endothelial lining at the time of implantation and as a result blood is exposed to
foreign surfaces, often resulting in a thrombogenic reaction which is amplified in the low
flow states associated with small calibre grafts [27, 91, 93]. Attempts have been made
to replicate the antithrombotic properties of the endothelium through drug elution of
antithrombotics, such as heparin, nitric oxide (NO), hirudin and aspirin [27], or by chem-
ical modification of the grafts luminal surface with immobilized heparin [15, 94, 95] or
carbon-coating to improve electronegativity of the surface [96,97]; however, for long term
patency a healthy endothelium is second-to-none [2,3,93]. Endothelial cell seeding, with
the patients own cells, onto the synthetic grafts surface prior to implantation has shown
efficacy in numerous trials [98–100]; however this two-stage procedure is expensive, in-
volves long waiting periods and has scalability issues due to the sophisticated clinical
facilities and cellular culture techniques required for it to become a true contender to the
autologous vessel [18, 42,91,93].
Currently it is understood that there are three different mechanisms of endothelial growth:
transanastomotic from the neighbouring native vessel; transmural from surrounding tissue
and fall-out from the blood stream. [3, 27]. In humans, transmural endothelialisation
seems to be the only option where transanastomotic growth is limited to about 10-20mm
from the anastomosis and fall-out leads to small ”islands” of endothelialisation rather
than a confluent surface. [3, 16, 27]. Thus it can be appreciated why promising animal
studies with synthetic materials have met with disappointing results in clinical trials,
where current synthetic grafts, ePTFE and PET, do not have sufficient porosity to allow
for transmural endothelialisation [2, 3, 16].
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Intimal Hyperplasia: Intimal hyperplasia is believed to be caused due to subopti-
mal haemodynamic and biomechanical properties over the anastomotic region. These
properties include: [3, 92]
• Compliance mismatch between the stiff graft and the more elastic vessel.
• Flow rate variations due to sudden changes in diameter between the native vessel
and prosthesis.
• Shear rate variations caused by the diameter change between the native vessel
and prosthesis.
The difference in compliance between small diameter ePTFE (Cd = 1.6±0.2% /100mmHg)
/ Dacron (Cd = 1.9±0.3% /100mmHg) [5,78,97] grafts and native vessels (femoral artery
= 7% to 14% /100mmHg, popliteal artery = 5% to 9% /100mmHg [21, 101, 102]), is
believed to be linked to intimal hyperplasic response [5, 103]. Salacinski et al (2001)
observed a highly significant (p=0.019) correlation (r2=0.877) between compliance and
graft patency, where more compliant grafts ( 5 %/100mmHg) exhibted higher patency
rates than less complianct grafts ( 2 %/100mmHg) [92]. Trubel et al (1994) found that
constriction of venous grafts (reversed deep femoral vein) with an outer Dacron mesh
tube, resulted in significant (p=0.001) increases to intimal hyperplasia at the distal anas-
tomosis when compared to unrestricted vein grafts (femoropopliteal bypass, sheep model,
n=12) [104]. Ballyk et al (1997) suggested, in a numerical model study, that increased
intimal hyperplasic response in graft materials with unmatched compliance to the native
artery is due to increased suture line stresses at the site of anastomosis [105].
Tai et al (2000) found that PU grafts almost exactly matched the average compliance
of muscular arteries, offering them a potential advantage over Dacron and ePTFE grafts
[106]. However, the compliance of PU grafts is largely dependant on the chemical make-
up and ratio of hard to soft segments of the material as well as the method of fabrication
of the graft [55,78,79].
It has also been shown that the presence of an even and healthy layer of endothelial
cells aids in preventing the proliferation of smooth muscle cells known to cause intimal
hyperplasia, indicating the importance of having a confluent endothelial lining for graft
patency [14].
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2.2 Electrospinning
2.2.1 Overview of Electrospinning
Electrospinning utilises high voltage electric fields to create nano-to-micrometer diameter
polymer fibres. In the case of solution electrospinning, the polymer is dissolved in a
suitable solvent and dispensed at a constant flow rate with appropriate equipment (e.g.
syringe and metered pump or reservoir air pressure through a spinneret (capillary with
a controlled aperture size) [107]). A high voltage differential is then created between
the spinneret and collector (10-40kV depending on application) with a suitable distance
between them. The polymer solution becomes highly charged at the nozzle tip and
eventually overcomes its own hydrostatic forces, forming the characteristic conical shape
known as the Taylor cone [108], to eject in a thin fibrous jet which then deposits on the
collector. The pattern of motion of the jet changes as it travels from the nozzle to the
collector. Initially travelling in a straight line but after a short distance begins to spiral
in a phenomenon known as bending/whipping instability [109,110] (Figure 2.3).
Bending instability is, simply-put, a result of the repulsive forces between adjacent, like-
charged particles in the jet acting to repel sections perpendicularly-and-outward to the
motion of the jet, thereby resulting in a parabolic shape [110–114] (See Figure 2.4).
There are many variations of electrospinning techniques depending on the desired out-
comes of the process, these modifications include but are not limited to: spinneret de-
sign (co-axial [115–122], tri-axial [123, 124] and needleless [125]), collector design (tubu-
lar [69, 126, 127], patterned [128] and temperature controlled [129]), electric field manip-
ulation (jet polarity [130], AC electrospinning [131] and electrostatic guidance [126,132])
and control of ambient conditions [133].
2.2.2 Brief History of Electrospinning
The relationship between electrostatic forces and the surface tension of a liquid droplet
was first quantified in 1882 by Lord Rayleigh [135]. Three and a half decades later, Zeleny
was able to photograph and describe the phenomenon of a liquid droplet overcoming its
own surface tension due to electrostatic forces [136]. In 1964 Taylor expanded on Zeleny’s
work and determined the critical angle of the conical interface (49.3◦) between two fluids
in an electric field, which was thereafter named the Taylor cone [137].
It wasn’t until 1934 that the first patent for electrospinning was filed by Anton Formhals
as a commercially viable invention [138], and almost half a century later the first patent
detailing electrospun vascular grafts was filed by G. Martin and I. Cockshott in 1977 [139]
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Figure 2.3: Diagrammatic overview of electrospinning equipment and process with a sy-
ringe pump and rotating collector. The syringe pump maintains a steady flow rate to
replenish the polymer mass being converted into a jet. Electrostatic elongation forces
overcome viscous and surface tension forces of the fluid, forming a Taylor cone and fi-
brous jet at the spinneret tip. The jet follows a linear path between the nozzle and
collector initially but then whipping instability ensues. The jet eventually collides with
and accumulates on the collector to form a fibrous tube. [134]
Figure 2.4: A cropped segment of an electrospun jet with uniformly spaced, positively
charged particles. The adjacent particles exert a repulsive force on one-another causing
the intermediate particles to be forced outwards forming a parabolic shape. [110]
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and two more shortly after in 1979 and 1983 by A. Bornat and T. How, respectively
[140, 141]. However, the adoption of electrospinning in research was slow until the mid
1990s when it became of interest in the field of nanotechnology to Reneker et al [142]
and a few years later in vascular graft development to Chaikof et al [143] and Bowlin et
al [144,145].
Since then electrospinning research has accelerated, finding applications in multiple sec-
tors of industry, ranging from textiles to astronautical and medical engineering [109].
2.2.3 Electrospun Vascular Grafts
This section, while not attempting to provide an exhaustive review of progress in elec-
trospun vascular graft development, will outline some of the main streams of research in
the field.
Electrospinning has the ability to create nano-to-micrometer diameter fibrous, non-woven,
polymeric sheets [110], with advantages including ease of production, high throughput,
minimal waste, high surface area per unit volume, fibrous morphologies similar to those
of the extra cellular matrix (ECM) [146] and ability to incorporate drugs with diverse
elution profiles as well as spin both natural and synthetic polymers [122, 134, 147, 148].
As a result electrospinning has been widely researched as a method of producing scaffolds
for tissue engineering and regenerative medicine approaches for musculoskeletal, nervous,
skin and cardiovascular applications [147–152]. Additionally, for the specific application
of vascular prostheses, electrospinning allows for easy fabrication into tubular constructs
(multi-layered with different polymers if required [153, 154]) where the fibre orientation
can be controlled.
A prominent stream of electrospinning research aims at improving the healing outcomes
of electrospun vascular grafts by spinning conduits from solutions of natural instead of
synthetic polymers. Natural polymers, such as collagen, elastin, fibrinogen, silk and
gelatin, are electrospun in the same fibre diameter scale as the native ECM and contain
an abundance of binding domains for cellular attachment, which are critical for cellular-
matrix interactions [149,150,155]. However, synthetic polymers, while lacking the binding
moieties of their natural counterparts, are stronger, more cost effective and customizable
and carry less risk of viral/disease transmission [155]. Strategies to improve the me-
chanical properties of natural polymers include cross-linking to improve strength and
decrease water solubility [156], however, cross-linking often adversely effects binding site
density/function and scaffold morphology [155, 157]. Synthetic polymers can be surface
treated [158–164] to improve their cellular interaction properties, however the obtained
surface characteristics are still thought to be inferior to natural polymers [155]. In an
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attempt to obtain the attractive properties of both polymer types, hybrid scaffolds of the
two have been produced where layers of each polymer are electrospun in layers, where the
natural polymer provides for cellular interaction and the synthetic provides mechanical
strength [153,155,165–167].
Another method aimed at improving patency of electrospun vascular grafts is by elution
of anti-thrombotic/anti-coagulative drugs from the electrospun fibres. Wang et al (2013)
used coaxial electrospinning to incorporate a heparin core inside a PCLA sheath which
facilitated the controlled release of heparin in vivo, improving patency over non-heparin
eluting PCLA scaffolds [168].
Table 2.2 summarises the in vivo circulatory studies found in literature where electro-
spinning was used to create vascular grafts. Note that while most studies exhibited high
patency rates and obtained confluent endothelial layers, the combination of short graft
lengths (<50mm) and poor cellular infiltration indicates that the mode of endotheliali-
sation was likely transanastomotic and thus it is unlikely that these positive results will
translate to human trials [3, 16]. It is also interesting to note that while the majority of
studies report on fibre diameter, few report on graft porosity and pore size. Where higher
porosity scaffolds were compared with those of lower porosity, an associated increase in
transmural cellular infiltration was observed from the adventia [67,169].
While transmural angiogenesis may prove a better predictor of transmural endotheliali-
sation than cellular infiltration, only two of the in vivo circulatory studies (Hashi et al,
2010 and Pektok et al, 2008) reported on angiogenesis and even then their reporting was
qualitative rather than quantitative [163, 170]. For the purposes of this review it was
more effective to report on cellular infiltration because it is sensible that increased cellu-
lar infiltration will correlate with increased angiogenesis (in order to supply nutrients to
the cells deeper into the scaffold wall. Thus cellular infiltration would provide an indirect
method of predicting capillary infiltration. It can be appreciated that more studies on
large-pore, high porosity electrospun vascular graft scaffolds are required to determine
the effects of advential cellular ingrowth and vascularisation on graft patency.













































As-spun PCL 2.0 13 Rat (AA) 12 9/9 12 NR 1.9 NR NR [172]
As-spun PCL 2.0 13 Rat (AA) 24 15/15 6 50% 1.9 NR NR [170]
As-spun PCL 2.0 10 Rat (AA) 78 3/3 13 40% 2.2 NR NR [90]
Bilayer PCL (HPa/LPb) 2.0 20 Rat (AA) 12 5/5c&d 12 35%c/12%d 2.2a/0.8b 83%a/65%b 9a/3b [169]
PCL+Paclitaxel surface mod. 2.0 NR Rat (AA) 24 3/3 24 55% 1.6 NR NR [158]
PCL+CAG surface mod. 0.7 7 Rat (CCA) 6 6/8 2 NR NR NR NR [159]
PCL+RGD surface mod. 2.2 15 Rabbit (CCA) 4 5/5 4 NR 0.5-3.0 NR NR [160]
PCL+Heparin surface mod. 2.0 40 Dog (FA) 4 4/4 4 NR NR 83% NR [161]
PCL:Collagen blend (1:1) 4.75 40 Rabbit (AIB) 4 7/8 NR None 0.52 NR NR [165]
PCL/chitozan/pNSR32 blend 1.2 15 Rat (AA) 8 NR NR Yes (NR)e NR NR NR [166]
PCL+Heparin surface mod. +
PU layer
2.5 40 Dog (FA) 8 5/6 Yes NR 0.15/0.2-1 49% NR [162]
ES elastin + ES PCL sheath 2.8 20 Rabbit (CCA) 4 3/3 NR NR 1.67 NR NR [153]
PLLA
Rolled MSC seeded PLLA sheet 0.7 NR Rat (CCA) 7.5 NR 5 Yes 0.5 NR NR [173]
PLLA + hirudin surface mod. 1.0 7 Rat (CCA) 26 6/7 5 Min 2 NR NR [163]
PCLA
PCLA + collagen coating 1.0 10 Rabbit (EGV) 7 3/3 No None 0.47 NR NR [174]
Coaxial PCLA (Heparin core) 2.5-3.5 50 Dog (FA) 4.5 1/4 2 None NR NR NR [175]
EC seeded coaxial PCLA
(Heparin core)
4.0 50 Dog (FA) 24 7/8 Yes NR <1 NR NR [168]
EC seeded coaxial PCLA
(Heparin core)
4.0 50 Dog (FA) 24 3/4 Yes NR 0.32 NR NR [176]
PU
PEUU/PMBU blend (85:15) 1.3 10 Rat (AA) 8 6/9 Yes None 0.5 NR NR [177]
PEUU s/ PMA surface mod. 1.3 10 Rat (AA) 8 11/12 8 None 1 NR NR [164]
PellethaneR© as-spun 1.5 15 Rat (AA) 26 10/10 Yes Min 0.88 NR NR [66]
PU HPa/LPb 1.5 15 Rat (AA) 26 7/7a&b 4 Moda/Minb 1.0a/0.9b 80%a/53%b 4a/2b [67]
TPU as-spun 1.6 20 Rat (AA) 52 14/14 4 Mod 1.4 75% 4.7 [178]
*= Patency of longest implant duration sample set, a= High Porosity, b= Low Porosity, c= Inside Barrier, d= Outside Barrier, e= No Quantitative Value, ESVG= Electrospun Vascular Graft, GID= Graft Inner Diameter,
GL= Graft Length, Dur.= Duration, End.= Confluent Endothelium, Cell Inf.= Adventitial Transmural Ingrowth, FD= Fibre Diameter, PS= Pore Size, PCL= poly(ε-caprolactone), PLLA= poly(l-lactic acid), PCLA= poly(ε-
caprolactone-co-L-lactic acid), PU= Polyurethane, PEUU= poly(ester urethane)urea, TPU= thermoplastic polyurethane, PMBU= poly(2-methacryloyloxyethyl phosphorylcholine-co-methacryloyloxyethyl butylurethane), PMA=
phospholipid copolymer, CAG= cysteine-alanine-glysine trimer peptide, RGD= arginine-glycine-aspartic acid, mod.= modification, AA= Abdominal Aorta, CCA= Common Carotid Artery, FA= Femoral Artery, AIB= Aortoiliac
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2.2.4 Control of Fibre Morphology
The variables affecting electrospun fibre morphology are numerous and, in an attempt to
logically sort them, have been categorized into process and solution parameters as well
as ambient conditions, as described in the sections to follow.
2.2.4.1 Process Parameters
Applied Voltage The applied voltage has the most prominent impact on fibre forma-
tion but is also the most ambiguous in its effects [134,148]. The general rule of thumb is
that fibre diameter decreases with an increase in applied voltage, up to a point [134,179].
Deitzel et al studied the fibre formation of a Poly(ethylene oxide) (PEO) solution in
water over a range of applied voltages. The authors noted the following: 1) jet formation
only occurred over a certain threshold voltage; 2) a continuous fibrous jet was observed
with increasing applied voltage until a ”critical voltage”, where the onset of beading
abnormalities begins; 3) above the critical voltage bead density increases with applied
voltage [180].
However, Reneker et al (2000) observed that large diameter jets, produced from highly
viscous and concentrated solutions, displayed branching when spun at supra-critical volt-
ages [110, 114]. Branching is the term given to the anomaly of secondary jets ejecting
perpendicularly to the primary jet as it traverses towards the collector; caused by the
repelling of diametral undulations in the primary jet by surrounding charges into smaller
secondary jets [181].
To summarize, the relationship between the applied voltage and fibre morphology is
not of a monotonic nature [134, 148]. There exists an optimal applied voltage setting
(normally accompanied by the formation of a stable Taylor cone as seen in Figure 2.5)
which is co-dependent on the solution system being spun as well as the other process
parameters [180].
Figure 2.5: Effects of applied
voltage on Taylor cone forma-
tion. Abnormalities occur at
both too high and too low
voltages with the ”sweet spot”
for fibre formation existing in-
between. [134]
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Solution Flow Rate After applied voltage, the solution flow rate is the next most
influential parameter on fibre morphology [134]. The flow rate not only has an effect on
fibre diameter but also on fibre porosity and shape [134].
As with applied voltage, there exists multiple critical values for solution flow rate where
if exceeded, effects on fibre morphology differ drastically. At the one extreme, when flow
rate is too low to replenish the volume of solution being converted into the fibrous jet,
then beaded morphologies occur [108].
Exceeding this minimum flow rate the fibre diameter increases proportionally to the flow
rate up to the upper critical value. In the cases where the solution vapour pressure
favours pore development, the density of the nano-pores observed on the fibre surface
also increased with increasing flow rate [182].
When the flow rate exceeds the high-level critical value, beaded abnormalities occur due
to insufficient time for the solvent in the fibrous jet to evaporate before deposition on the
collector (”wet” deposition). If a majority of the fibres deposited wet, then agglutination
of the fibres occurs and in the most severe cases, a film-like morphology develops [116,
180, 183]. The density of both beaded and shape defects increases with increasing flow
rates thereafter [182].
Working Distance The distance the fibrous jet needs to travel before colliding with
the collector is known as the working distance (also known as the capillary to collector
distance). This distance can affect the diameter of the formed fibres by 1 - 2 orders of
magnitude [134].
Taylor first observed that the diameter of the jet decreased as the jet travelled further
away from the capillary tip [108], with further studies coming to the same conclusion
[142,184]. It was also found that if the capillary to collector distance was too short then
beaded and agglutination morphologies occurred; this was attributed to insufficient travel
time for the jet to evaporate [182,183].
To summarise, for increasing capillary to collector distance the fibre diameter decreases
and the fibrous jet has more time to evaporate.
2.2.4.2 Solution Parameters
Polymer Molecular Weight Gupta et al (2005) observed that molecular weight plays
a critical role in determining whether a polymer is electrospun into fibres or electro-
sprayed into beads [185]. They found that low molecular weight poly(methyl methacry-
late) (PMMA) formed droplets (electrospraying) due to insufficient chain overlap for fibre
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formation; as molecular weight increased so did fibre formation, with decreasing quantity
of beaded abnormalities. They also noted that solutions with narrow molecular weight
distributions produced more uniform fibre morphologies with fewer beads than those with
wider molecular weight distributions.
Nezarati et al (2013) noted a similar trend when spinning two different batches of
poly(carbonate urethane) (PCU) under the same conditions. They found that the in-
herent batch-to-batch variability was sufficient to make observable differences in fibre
formation [133]. The first batch (Mw = 241kDa) produced uniform and dry fibres whereas
the second batch (Mw = 217kDa) resulted in beaded fibres being formed. They hypothe-
size that the effects of molecular weight on fibre morphology are indirectly caused through
a corresponding change in solution viscosity.
Polymer Concentration The polymer concentration directly influences both solution
viscosity and surface tension, which in turn are fundamental in determining whether fibre
or a droplet is formed during electrospinning [134,180].
If the solution is too dilute then the force of surface tension will dominate, causing
droplets to be formed instead of continuous fibres. On the other hand, if the solution is
too concentrated then it will be difficult to control the polymer flow rate to the tip of the
collector due to the increased viscosity [134,180].
Between the two extremes exists an optimum range where continuous fibres can be pro-
duced. Within this optimum range it has been observed that fibre diameter increases
with increasing polymer concentrations (Figure 2.6) [134,180,186].
Figure 2.6: Average fibre diameters of
electrospun Poly(ethylene oxide) (PEO)
spun from DI water over various solution
concentrations. Primary distribution is
represented by circles and secondary by
squares. It can be seen that within the
optimal range of solution concentrations
the fibre diameter increases with increas-
ing concentration. [180]
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Solution Conductivity The solution conductivity is directly related to the solutions
charge carrying capacity. The greater the charge carried by the solution, the greater the
tensile force applied on the jet by the electric field, resulting in longer, thinner fibres
[122,134,187,188].
Increasing the solution conductivity has also been shown to produce more uniform fibres
with fewer beaded deformations [148, 188]. Increasing the solution conductivity can be
accomplished by adding ionic salts to the solution, where the salts ionize and increase
charge density. Zong et al (2002) tested the effects of three different salts (KH2PO4,
NaH2PO4 and NaCl), in a solution of poly(D,L-lactic acid) PDLA in dimethylformamide
(DMF), and found that in all cases there was a reduction in bead deformations and fibre
diameter (Figure 2.7) [188].
(a) Without NaCl Additive (b) With NaCl Additive
Figure 2.7: SEM images of fibres spun from 30 wt% solutions PDLA/DMF with all pro-
cess parameters held constant bar solution conductivity. a) Resultant fibre morphology
without NaCl additive; note the irregular fibre diameter and presence of beads. b) When
NaCl is added to the solution the resultant increases in solution conductivity causes a
reduction in bead formation as well as fibre diameter [188]
.
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Solvent Dielectric Constant The dielectric constant is an indicator of a materials
ability to hold charge in an electric field. It has been observed that solvents with high
dielectric constants are able to produce fibres with smaller diameters and reduced beading
defects [133,189].
Wannatong et al (2004), when spinning polystyrene (PS) fibres, found that solvents
with higher dielectric constants (m-Cresol and DMF) produced thinner fibre diameters
with more uniform distributions at higher productivity rates (number of fibers produced
per unit area, per unit time) than solvents with lower dielectric constants (Toluene and
THF). They hypothesise that solvents with high dielectric constants have an increased
susceptibility to the applied electric field, which in turn increases the drawing force on the
jet, acting to simultaneously elongate the fibres and increasing mass throughput through
the spinneret [183].
Solution Viscosity It is widely accepted that the change in solution viscosity is the
key driving factor in the morphological effects observed when adjusting the solution
concentration and molecular weight [133,134,142,180].
As observed with solution concentration, there exists a minimum and maximum thresh-
old for a given polymer where a continuous fibre will be formed. Under the minimum
threshold, the force of surface tension will cause the fibre to break apart into beads due
to Rayleigh Instability [133]. Above the maximum threshold, continuous fibres will be
difficult to produce due to the flow rate fluctuations through the spinneret caused by the
high viscosity [133,134].
In-between the above stated minima and maxima values it has been observed that fibre
diameter increases with increasing viscosity [133,134,180].
Solvent Volatility Solvent volatility has been shown to be related to the production
of nano-pores on the fibre surface. Megelski et al (2002) spun PS in varying mixtures of
tetrahydrofuran (THF) and dimethylformamide (DMF) and studied the morphological
effects on the resultant fibre formation [182]. They found that solutions made in 100%
THF (more volatile) exhibited greater pore density (number of pores per unit area) than
mixtures of THF and DMF. Fibres spun in DMF (less volatile) showed no signs of nano-
pores [182]. They concluded that nano-pore formation was dependant on the vapour
pressure of the solvent, with increasing solvent vapour pressures leading to an increased
number of nano-pores formed.
Wannatong et al (2004) found that (when spinning PS in m-Cresol, Toluene, THF or
DMF) fibre diameter decreased exponentially with increases in solvent boiling point,
they hypothesize that this is due to the jet’s inability to reduce in diameter once it
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had completely evaporated (dry), thus for high volatility solvents (THF and Toluene)
the jet would dry much sooner along their flights and hence would not have had time
to elongate and thin as much as their low volatility counterparts (DMF and m-Cresol)
[183]. However, in a study by Luo et al (2010) it was argued that the difference in fibre
diameters observed between solvents are dominated by their dielectric properties rather
than volatilities; where they found that fibres spun from methanol and THF (with boiling
points of 65◦C and 66◦C and dielectric constants of 32.6 and 7.6, respectively) had average
fibre diameters of 0.4µm and 3.5µm, respectively.
2.2.4.3 Ambient Conditions
While it is known that environmental conditions such as ambient temperature, air veloc-
ity, atmospheric composition and pressure play a role in the outcome of the electrospin-
ning process [122,142], there has been limited work specifically describing their effects.
Environmental Humidity Nezarati et al (2013) studied the effects of both humidity
(5% - 75%) and solution viscosity on the resultant fibre morphologies when electrospin-
ning three different polymers; namely poly(carbonate urethane) (PCU), polycaprolactone
(PCL) and poly(ethylene glycol) (PEG) [133]. It was observed that at low humidity val-
ues fibre breakage would occur; however, the effects of high humidity values depended on
the properties of the polymer being spun. For instance PCL developed nano-pores on the
fibre surface, while PEG showed signs of beading. Megelski et al (2002) also observed
increased pore density when increasing relative humidity while spinning PS in a THF
solution. [182]
Nezarati et al concluded that the effects of humidity on electrospinning of a particular
polymer vary depending on the solvent volatility and miscibility as well as the polymer
hydrophobicity. Their work also suggests that each polymer has its own optimal humidity
value for the creation of smooth, regular fibres.
2.2.4.4 Summary
Table 2.3 summarises the effects of the different process and solution parameters on the
morphology of the spun fibres.
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2.2.5 Controlling Scaffold Properties
Since the sudden increase of electrospinning activity in the 1990s many fields of research
have attempted to suit the process to their specific needs. As a result there has been a
multitude of different techniques and set ups developed for controlling bulk scaffold prop-
erties (fibre alignment, porosity, pore-size etc.). Techniques of note in the development
of vascular grafts are fibre alignment and porosity control which will discussed separately
in the sections to follow.
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2.2.5.1 Fibre Alignment
Fibre alignment is an important factor for both scaffold mechanical properties (strength,
elasticity etc.) and cell adhesion, alignment and function [127, 193, 194]. Drilling et al
(2009) argue that complete fibre alignment is not necessary or even favourable for the
development of burst pressure competent electrospun grafts, and suggest that a degree of
isotropy is favourable for producing grafts that can resist surgical handling, suture stress
and sheer stresses associated with pulsatile flow; while still retaining sufficient strength
to resist burst pressures greater than those of the native vessel [127]. On the contrary,
it has been shown that cellular alignment, differentiation and function are influenced by
synthetic fibre alignment, thus in order to reproduce the structure of the circumferentially
aligned tunica media in native vessels, a degree of fibre alignment is required to help guide
cell differentiation and function [193,195,196].
As a result of the diverse applications of electrospinning and fibre alignment requirements
thereof, a variety of collector types are available to tailor fibre alignment, some of these
will be discussed in this section.
Electrostatic Collectors The fibre alignment can be manipulated by tailoring the
electrostatic properties of the collector. Xie et al (2010) utilised a double U-shaped
collector to produce aligned fibres between two sets of randomly orientated fibres [197].
The electric field created by the uniquely shaped collector caused the fibres to collect
on the flat sections of the collector but stretch across in-between. They hypothesized
that this fibre morphology would be well suited for assisting in tendon repair by seeding
fibroblasts into the fibrous mesh.
Magnetic Alignment Yang et al utilised magnetic fields created by two permanent
magnets to align fibres spun onto a flat collecting plate [198]. They doped poly(vinyl
alcohol) (PVA) with Fe3O4 nano-particles to allow the fibrous jet to be influenced by
the magnetic field. The method, coined magnetic electrospinning (MES), was able to
produce mats where up to 75% of the fibres were parallel to each other (0 - 5deg).
However, the effects of the presence of Fe3O4 nano-particles in the deposited fibres on
biological response and mechanical properties requires further testing.
Rotating Mandrel Fennessey et al (2004) found that by increasing the surface velocity
of a rotating mandrel collector they could produce a narrower alignment distribution of
electrospun fibres (Figure 2.8) [199]. By varying either the diameter or the rotational
speed of the mandrel, the surface velocity where the fibre collides with the collector
can be manipulated, thus rotational speed is a useful parameter for controlling fibre
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alignment. Additionally, this method collects fibres in a tubular form, which is useful in
the application of vascular grafts, where diameter can be varied by changing the diameter
of the mandrel. See Figure 2.3 for a diagrammatic representation of a rotating mandrel
system.
Figure 2.8: Optical micrograph of electrospun polyacrylonitrile (PAN) fibres spun from
DMF. Fibres were collected at surface velocities of a) 0 m/s b) 3.5 m/s c) 6.1 m/s and
d) 12.3 m/s. The arrow indicates the direction of motion. [199]
2.2.5.2 Porosity Control
Porosity, pore size and pore-interconnectivity are critical factors influencing cellular in-
filtration, viability and growth in 3-dimensional scaffold structures [3, 150]. A major
challenge of electrospinning has been to create large, interconnected pores, due to the
tightly packed fibrous meshes that are created under normal conditions. As a result
there has been much research and a variety of methods investigated for improving and
controlling these critical porosity factors. See Table 2.4 for a summary of the methods
used to increase porosity and pore size in literature.
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Fibre Diameter and Packing Density It has been shown that porosity and pore
size can be increased by increasing the diameters of the fibres within the scaffold [75,
132, 200–204] and are related to the packing density of the fibres [67, 132]. However,
smaller fibre diameters are desired for cell adhesion [74–76,203] and packing density was
increased in these studies rather than decreased through the manipulation of electric
fields (by guiding deposition with electrostatic rings surrounding the path of the jet),
thus offering no way to further improve porosity from standard means. Additionally,
Milleret et al (2012) observed that the blood coagulation reaction to electrospun vascular
grafts produced from Degrapol and PLGA favoured smaller diameter fibres [202]. Where
larger fibre diameters correlated with higher thrombin formation and platelet adherence,
indicating that increasing pore size by means of increasing fibre diameter may lead to
undesirable increases in thrombogenicity when used in vascular graft applications.
Custom Collector Designs Modified collectors which have been specifically designed
for increasing porosity and pore size, ranging from patterns in the collector surface to re-
frigerated drums for freezing fibres and local moisture on collection, are found throughout
literature and will be discussed below.
Patterned collectors are able to create local electric field gradients which alter local fibre
deposition morphology. Zhu et al (2008) used a rotating frame (Figure 2.9a) to alternate
the alignment of the fibres spanning adjacent struts, which for different rotational speeds
altered fibre packing density [205]. Similarly, Vaquette et al (2011) utilized flat plate
collectors with a myriad different patterned holes to improve local pore size (Figure
2.9c).
McClure et al (2012) used an internally pressurised collector mandrel which was patterned
with small holes connected to a compressed air supply, allowing for air flow through
the small holes in the mandrel to reduce local fibre packing density. They tested the
effects of various internal pressures (0-200 kPa) and found that 100 kPa produced the
largest pore sizes (7.6±3.1 µm) between fibres collected within the patterned regions and
showed improved cellular penetration in these regions when compared to scaffolds spun
on standard collectors [206].
Perhaps the most creative of these electric field modifying patterns is that aptly, albeit
forcibly, named Focused, Low density, Uncompressed nanoFiber (FLUF) which consists
of a hollowed-out half-sphere shaped collector with an array of pins extruding out of the
inner surface, causing fibres to discharge at different depths into the bowl resulting in
a low density, ”fluff-ball” (Figure 2.9e) [207]. Also along the lines of custom collector
designs, Simonet et al (2007) utilized a collector drum loaded with dry ice and a humid
environment to decrease packing density by separating fibres with ice crystals which were
Chapter 2: Literature Review 29
University of Cape Town Department of Biomedical Engineering
subsequently dried, creating large pores in their wake. This method has been named Low
Temperature Electrospinning (LTE, Figure 2.9g) [129,208].
While these techniques have shown efficacy in reducing fibre packing density, each have
their own shortfalls with regard to application in small diameter vascular grafts; whether
it be scalability (4-6mm diameter collectors) in terms of the rotating strut frame and LTE
or difficulty in removing cylindrical constructs such as in patterned or FLUF collectors.
Dual Electrospinning Dual-spinneret, co-spinneret or side-by-side spinning set ups
were initially devised to create constructs which combined attractive properties of two
different materials [209–211]. It was not until later that Baker et al (2008) utilized this
approach for improving the porous characteristics of electrospun meshes [212]. The two
primary approaches utilising dual-spinnerets are dual electrospinning and electrospin-
ning/electrospraying. Each method will be discussed in detail below.
Dual electrospinning was first utilised as a method to improve porosity characteristics by
Baker et al (2008) where poly(ethylene oxide) (PEO) and poly(σ-caprolactone) (PCL)
were spun simultaneously and the PEO fibre was subsequently washed out, leaving only
the PCL fibres remaining with void spaces in the wake of the PEO fibres (Figure 2.10).
This process was coined porosity control via ’sacrificial fibres’ [212]. This method allowed
for improved porosity while still maintaining structural anisotropy. When various scaf-
folds were seeded with mesenchymal stem cells (MSCs), they found that with increasing
percentages of PEO content cellular infiltration was improved. However, this was at the
cost of mechanical strength and at PEO contents above 60% the scaffold structure would
deform on removal of the sacrificial fibres. Since then the method has been shown to
increase porosity and pore size in numerous studies [71, 213–215].
A slight modification of electrospinning with sacrificial fibres is to incorporate electro-
sprayed porogens into the scaffold architecture, this is precisely what Ekaputra et al
(2008) first explored when they spun PCL/Collegen blends with electrosprayed Heprasil
(hyaluronic acid/heparin hydrogel) [216]. This study reported that the hydrogel produced
significantly larger pore sizes which resulted in improved cellular infiltration. However,
the process of electrospraying a hydrogel adds more complexity to the electrospinning
process and required that the solution be spun within 30 minutes of preparing the Hep-
rasil solution, which adds limits to spinning time and hence scaffold thickness. A similar,
somewhat simpler, process was explored by Nam et al (2007) where NaCl crystals were
deposited onto the collector mandrel while electrospinning and subsequently removed by
immersion in water, producing large pores; however, the pores were found to be in the
form of delaminations rather than homogeneous interconnected pores [217].
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(a) Zhu et al : Strutted frame [205] (b) Zhu et al : Resultant fibre morphology
[205]
(c) Vaquette et al : Pat-
terned collector [128]
(d) Vaquette et al : Resul-
tant fibre morphology [128]
(e) Blakeney et al : FLUF
collector [207]
(f) Blakeney et al : Comparison of stan-
dard vs FLUF scaffold [207]
(g) Simonet et al : LTE collec-
tor [129]
(h) Simonet et al : Comparison of standard
vs LTE scaffold [208]
(i) McClure et al : Air-
Impedance [206]
(j) McClure et al : Fibrous mor-
phology over ”blow-hole” [206]
Figure 2.9: Custom collector designs utilized to decrease fibre packing density and thereby
increase pore-size and porosity.
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(a) SEM image of scaffold before PEO removal
(2008)
(b) SEM image of scaffold after PEO remvoval by
water immersion
(c) Schematic diagram of dual-electrospinning set
up
(d) Photograph of dual-electrospinning aparatus
Figure 2.10: Baker et al (2008): SEM images of scaffold architecture a) before removal of
PEO and b) after removal through submersion in water. Note the improvement in pore-
size. c) Schematic of electrospinning set up for dual electrospinning d) The electrospinning
set up utilized two spinnerets charged with like-polarity on either of a grounded mandrel.
The spinnerets were guided by custom built ’fanners’ to evenly distribute fibres over the
length of the mandrel. In order to prevent the like charged fibrous jets from repelling
each other to opposite ends of the collector they utilized charged electrostatic shields on
either side of the mandrel [212].
Other Methods Some notable methods recently used to increase porosity and create
larger pores cannot be grouped into any of the classifications above and thus will be
discussed separately.
Cai et al (2013) doped Zein and PEG solutions with sodium dodecyl sulfate (SDS) which
they showed to increase surface conductivity of the resultant electrospun fibres. They
hypothesize that when these fibres came in contact with the oppositely charged collector
they inherited the charge of the collectors, thereby creating a net repulsion force between
the collector and the fibres, acting to reduce fibre packing density [218]. This method,
however, requires that SDS be soluble in the polymer solution and also may leave traces
of SDS in the fibre structure.
Lee et al (2011) utilized high power ultrasonication to decrease the packing density of
poly(L-lactic acid) (PLLA) fibrous scaffolds after spinning as a post-processing step. They
found that pore sizes could be increased from 2.1±0.6µm to 13.5±6.8µm by varying the
sonication energy the scaffolds were exposed to [219]. However, this technique has yet to
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be shown with elastic materials such as polyurethanes and it may be that the stiffness of
PLLA is critical for the efficacy of this technique [220,221].
Another study which used a post-processing step to produce large pores was performed
by Lee et al (2012) where a femptosecond laser was used to create circular holes with
controllable depth and diameter by varying laser energy and number of pulses, respec-
tively [222]. This technique, while simple and effective, requires specialized equipment
and creates radial holes rather than three dimensional pores [3].
Table 2.4 provides a summary of the techniques found in literature to improve porosity
and pore size of electrospun scaffolds.
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PCL N/A 40-60 a >90% TE in Vitro (HUVEC) [132]
PLCL & PLL
& PCL
N/A 50 75% TE in Vitro (HUVEC) [75]
DP & PLGA N/A 35-45 ND CV in Vitro (PHhWB) [202]
PCL &
Collagen
N/A 1.5-40 ND CV
in Vitro (hAEC &
hSMC) [203]













80 - 360f >90% TE None [223]
PCL FLUF 2 - 5 ND TE in Vitro (INS-1) [207]
PLGA & DP LTE ND >90% TE None [129]









7 ND CV in Vitro (hSMC) [224]
Dual Electrospinning with Sacrificial Fibres
PCL PEO ND ND MS in Vitro (hMSC) [212]
PCL PEO ND ND MS in Vivo (Rat SC) [215]
Acr-PGS PEO ND ND CVc / MS
in Vitro (NNC) &
in Vivo (Rat SC) [213]
TRI PEO 50 ND Bone in Vitro (hMSC) [214]
DP & PLGA PEG ND >85% TE in Vitro (FB) [71]
Continued on next page
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ND ND TE in Vitro (hFOB) [216]
PLA PEG ND >85% TE None [225]
SF PEO 30 >95% TE in Vitro (FB) [226]
PCL PEO 32 >95% CV in Vitro (FB) [227]





ND >99% TE in Vitro (FB) [218]




50-200 ND TE in Vitro (hMSC) [222]
a= Statistically calculated, b= Spacial Fibre Distance, c= Heart Patch (Not Vascular), d= Spinkled not
electrosprayed, e= Size of delaminations, f= size of pockets measured in side section SEM, TE= Tissue
Engineering, N/A= Not Applicable, ND= Not Determined, MS= Musculoskeletal, CV= Cardiovascular,
PLCL= poly(L-lactide-co-ε-caprolactone), PLL= poly(L-lactide), PCL= poly(ε-caprolactone), P(LLA-
CL)/SF = poly (l-lactic acid-co-ε-caprolactone)/Silk Fibroin, PLGA= poly(DL-lactide-glycolide), PLA=
poly(lactic acid), PEO= poly(ethylene oxide), Acr-PGS= Acrylated poly(glycerol sebacate), TRI=
PCL/collagen I/hydroxyapatite, PEG= Poly(ethylene glycol), DP= Degrapol R©, Col= Collagen, SF=
Silk Fibroin, PLLA= poly(l-lactic acid), Zein= A natural maize derived protein, HUVEC= Human Um-
bilical Endothelial Cell, hAEC= Human Aortic Endothelial Cell, FB=Fibroblast, hDF= Human Dermal
Fibroblast, HVSC= Human Vena Saphena Cell, hMSC= Human Mesenchymal Stem Cell, NNC= Neona-
tal Cardiomyocyte, hFOB= Human Fetal Osteoblast, hSMC = Human Smooth Muscle Cell, PHhWB =
Partially Heparinized Human Whole Blood, SC= Subcutaneous
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Chapter 3
Materials and Methods
This chapter describes the materials and methods used in this study. Firstly the mate-
rials used in the fabrication of the scaffolds will be discussed, Section 3.1, followed by
descriptions of the electrospinning methods utilised, Section 3.2. In Section 3.3 the hep-
arin surface modification process is described and in Section 3.4 the various methods of
characterising and assessing the scaffolds in vitro will be outlined. Section 3.6 provides
details on the protocol for the in vivo tissue response study and finally the statistical
methods used will be given in Section 3.7.
3.1 Materials
The polyurethane (PU) chosen as the scaffold material for this study, Pellethane R© 2363-
80AE (Lubrizol, Wickliffe, OH, USA), is a well-known medical grade polyurethane with
a glass transition temperature of -47◦C. PEO (Poly(ethylene oxide), 200kDa, Aldrich,
St-Louis, MO) was selected as a sacrificial material due to its rapid water-solubility
and widespread use in electrospinning literature. The solvents Tetrahydrofuran (THF),
Dichloromethane (DCM), Dimethylformamide (DMF), Methanol (MeOH), Ethanol (EtOH)
as well as Rhodamine and Fluoroscein Free Acid (FFA) were purchased from Sigma
Aldrich.
3.2 Electrospinning
3.2.1 Electrospinning Solution Preparation
All solution concentrations in this study are expressed as weight-per-volume percentages,
i.e. a 10% solution will contain 10g of solute in 100ml of solvent.
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3.2.1.1 Polyurethane
After literature reviews and own initial experiments a PU concentration of 15% was
decided upon for use in subsequent experiments. Two different solvent systems were
used: THF and a THF:DMF mixture (1:1), as will be described in more detail below.
THF is a commonly used solvent for electrospinning polyurethanes and is beneficial for
its low cost and low boiling point (66◦C), but suffers from a low dielectric constant (7.6).
DMF, with a dielectric constant of 36.7, was mixed in a 1:1 ratio with THF in an attempt
to improve the dielectric properties of the electrospinning solution. Pure DMF was not
investigated as a solvent due to its high vapour pressure which, in initial experiments,
resulted in fibres depositing on the collector before sufficient evaporation could occur,
leading to fibre agglutination. All samples were analysed for resultant fibre diameter,
fibre alignment and fibre deposition, Table 3.1 below summarises the experiment.
Table 3.1: PU Solvent System Comparison Parameters*
Solvent System Flow Rate (ml/hr) Sample Size
THF 0,75 2
THF:DMF (1:1) 2** 2
*All other electrospinning parameters were held constant: Spin Voltage = 20kV, Working
Distance = 20cm, Mandrel Diameter = 25mm, Rotational Speed = 5000rpm, Environ-
mental Temperature ≈ 20◦C, Relative Humidity ≈ 30%. **Flow rate was adjusted to
achieve a stable Taylor-cone. A small sample size was chosen due to the exploratory na-
ture of the experiment and the large differences in fibre morphology anticipated between
the groups (which has been shown in literature [190,228]).
For both solvent systems, homogeneous solutions were obtained by mixing all parts of
the solution in a sealed Pyrex R© 250ml bottle and placing in a roller oven for 24 hours at
40◦C.
3.2.1.2 Polyethylene oxide
For PEO, two different solvents were tested, DCM and 90%/10% EtOH/H2O. DCM was
used in an attempt to spin large diameter fibres due to its low boiling point (40◦C) and
low dielectric constant (8.9). Conversely EtOH, possessing a moderately higher boiling
point (78◦C) and a much higher dielectric constant (24.5), was utilized in the production
of small diameter fibres.
Solution concentration was set to 20% as it proved the highest value within the usable
viscosity range. Preliminary tests compared the resultant fibre diameters for DCM and
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EtOH solvents at a range of solution flow rates. Table 3.2 below summarises the experi-
mental parameters.
Table 3.2: PEO Solvent System Comparison Parameters*









*All other electrospinning process parameters held constant: Spin Voltage = 20kV, Man-
drel Diameter = 25mm, Rotational Speed = 5000rpm, Environmental Temperature ≈
21◦C, Relative Humidity ≈ 25%. **Working Distance adjusted between solvents as Tay-
lor cone would not form for DCM groups further than 10cm and for EtOH groups the jet
would not completely evaporate before deposition at distances closer than 20cm.
The solutions were made-up in 250ml Pyrex bottles and placed in a roller oven for 24
hours at 35◦C to ensure homogeneity and complete dissolution.
3.2.2 Electrospinning Equipment and Design
The electrospinning equipment used at the initiation of the project included two syringe
pumps (SE400B, Fresenius, Bad Homburg, Germany), an adjustable high voltage power
supply (custom made), a rotating and bi-directionally translating collector mechanism
with 24 volt power supply for rotation speed control and a separate custom made con-
troller for translation control. Two different collector mandrels, with large (25mm) and
small (5mm) diameters made of 316 Stainless Steel were used. The collector mechanism
was housed inside a specially designed box with a ventilation system fitted to safely re-
move any evaporated solvent created during the electrospinning process. Humidity and
temperature were measured using a thermo-hygrometer (Lasec, South Africa).
In order to accommodate the dual spinning process two additional high voltage power sup-
plies were obtained, one positive in polarity and the other negative (ES30P-5W/ES30N-
5W, respectively, Gamma High Voltage Research, FL, USA). Purpose built electrostatic
guides (1mm thick aluminium plate, 20mm x 100mm), for countering the repulsion force
between like-charged fibrous jets, were designed and manufactured in-house and erected
on either side of the rotating mandrel in parallel. Two blunted 16G hypodermic nee-
dles were used as spinnerets. See Figure 3.1 for 3D CAD renders of the final equipment
utilized.
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(a) Trimetric View
(b) Top view (c) Trimetric View (Inside Box)
Figure 3.1: 3D renders of modified electrospinning equipment for dual electrospinning.
Note the spinnerets positioned on opposite sides of the collector mandrel with electrostatic
shields erected parallel and offset to the jet direction. HVPS = High Voltage Power
Supply.
3.2.2.1 Tailoring the Electric Field for Dual Electrospinning
In an attempt to direct the deposition of the two polymer jets a variety of electric field
configurations were theoretically and experimentally assessed. Fundamentally there were
only three different electric field configurations that could be used: spinnerets charged
with the same polarity, spinnerets charged with opposing polarities and configurations
using alternating current (AC) electrospinning. This study investigated the effectiveness
of both like and opposing polarity configurations as well as modifications of each to further
improve the control over the electrospun jets; AC electrospinning was not investigated
due to the safety concerns associated with high voltage AC electric fields.
Chapter 3: Materials and Methods 39
University of Cape Town Department of Biomedical Engineering
3.2.3 Composite Scaffold Fabrication
The electrospinning parameters used for this study were chosen after an iterative process
of optimization.
PU was spun from a 15% solution in THF:DMF (1:1) at a constant feed flow rate of
3ml/hr and an applied voltage of +20kV at 200mm working distance.
Two different classes of PEO fibre were investigated, one comprising large diameter fibres
(thick) and the other small diameter fibres (thin, See Table 3.3). The large and small
diameter PEO fibres were spun from 20% solutions of DCM and 90%EtOH, respectively
and at distances of 100mm and 200mm, respectively. For both, the applied voltage was
set to +20kV. PEO solution flow rate was adjusted depending on the PU fibre fraction
required and ranged from 0ml/hr to 6ml/hr.
Aluminium shields were charged to +7kV and erected parallel to the jet trajectory on
either side of the rotating collector (5000rpm), at a distance of 90mm from the centre of
its midpoint, to better direct the deposition of the like charged polymer jets.
For the production of small diameter grafts a mandrel size of 5mm was used while in
the case where large samples were required for mechanical testing or in vivo studies
a larger 25mm mandrel was used. In either case the collector was charged to -1kV to
promote deposition on the mandrel. The collector was rotated at 5000rpm and translated
2.6mm/min over a distance of 30mm.
For all samples the recorded relative humidity and temperature were in the region of 20%
- 28% and 20◦C - 24◦C, respectively.
Description Graphic
Thick sacrificial fibres:
PU/(THF:DMF) & PEO/DCM - Large
diameter, aligned sacrificial fibres.
Thick groups (n=49)
Thin sacrificial fibres:
PU/(THF:DMF) & PEO/EtOH - Small
diameter, dispersed sacrificial fibres.
Thin groups (n=101)
Table 3.3: Thin and thick sacrificial fibres were experimentally assessed for differences
in porosity achieved after removal of their respective sacrificial fibres. Fibre fraction was
varied by controlling PEO flow rates (2ml/hr - 6ml/hr) for each group.
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3.2.4 Sample Preparation
Samples were prepared differently depending on the mandrel size used and the desired
use of the sample (Figure 3.2). Grafts spun on 5mm mandrels were cut to size while on
the mandrel and initiated into the PEO extraction process while still on the mandrel.
The grafts were then removed and dried.
Scaffolds required for in vivo studies were spun on a 25mm mandrel where only the centre
10mm was used (thickest part of the sample), the samples were cut to size (10mm by
10mm by approximately 1mm thick) and measured for exact size(as per section 3.4.5).
Samples were then processed for PEO extraction and drying.
Samples required for mechanical testing were spun on a 25mm mandrel and cut in the
circumferential direction 30mm long by 5mm wide. Samples required for testing in the
transverse direction were cut 30mm long in the transverse direction by 5mm wide. Sam-
ples were then processed for PEO extraction and drying.
(a) Grafts (b) In vivo Studies (c) Mechanical Testing
Figure 3.2: Graphical depiction of sample preparation process for each application. c)
Note both circumferential and transverse direction samples taken from one electrospun
sheet with paired samples in the circumferential direction. Blue and green lines indicate
transverse and circumferentially cut lines, respectively.
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3.2.5 PEO Extraction
PEO was extracted after spinning by immersion in gradually decreasing mixtures of
alcohol and deionised (DI) water, starting at 50% EtOH for 1 hour and then decreasing
by 10% per hour until only DI water remained.
Two different drying processes, lyophilization (freeze-drying) and vacuum drying, were
evaluated for their effects on scaffold shrinkage. The length of 100%, 70% and 40% fibre
fraction grafts were measured and recorded before undergoing the PEO removal pro-
cess and after drying (n=2). The final shrinkage values ( length before PEO removal
length after drying
) were
calculated and compared between drying methods for each fibre fraction. For lyophiliza-
tion, samples were frozen in liquid nitrogen (while immersed in water) prior to vacuum
exposure.
3.3 Heparin Surface Modification
Heparin was covalently bound to the surface of the PU fibres in a process which has been
previously described [15]. Briefly, the heparinization process involved rinsing scaffolds
(post PEO-extraction and lyophilization) in deionised (DI) water and immersion in a so-
lution containing: acrylic acid (4M, Aldrich, USA), acrylamide (1M, Aldrich), Cu(NO3)2
(0.1M, Saarchem Holpro, RSA) and, after removal of oxygen, cerium ammonium nitrate
(0.006M, Saarchem). Scaffolds were sonicated (Waterbath, 100W, UMC5, Integral Sys-
tems) in the solution for 40 minutes at RT, after which they were rinsed in DI water at
RT, exchanging water 3 times (once every 10 minute) and left overnight on a shaker.
The scaffolds were then aminated through reaction (2hr, sonication, RT) with ethylene
diamine (EDA, 0.5M, Fluka) in 2-(N-morpholino)ethanesulfonic acid buffer (MES, 0.5M,
pH=5, Fluka) containing 0.05M 1-ethyl-3(3-dimethyl-aminopropyl)carbodiimide (EDC,
Sigma) and rinsed in DI water.
Finally, heparin was covalently attached through reductive amination by treating (2hr,
50◦C, sonication) the aminated scaffolds with a solution of nitrous acid de-aminated
(NAD) heparin (2mg/ml, Celsus, USA) in an acetate buffer (0.4M, pH=4.6) sodium
cyanoborohydride (NaCNBH3, 0.016M, Sigma). The heparinized scaffolds were then
rinsed in DI water (3x10 minutes and overnight on shaker) and dried by lyophilization.
3.3.1 Qualitative Verification of Heparinization
Verification of each step in the heparinization process was achieved by using the same
staining technique as developed as described previously [15]. Toluidine Blue, a cationic
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dye, was used to stain the negatively charged carboxyl groups (blue) and heparin (purple)
in the AAc grafting and final heparinization steps, respectively. Conversely, Ponceau S,
an anionic dye, was used to stain the positive aminated structures of the second step (red).
Thus each stage of the process was monitored for efficacy before the next is initiated.
3.3.2 Quantitative Testing of Heparinization
Quantitative values for describing the degree of heparinization achieved were obtained by
means of a 3-methyl-2-benzothiazolinehydrazone-hydrochloride (MBTH) assay which has
previously been adapted by this group [15] from Riesenfeld and Rodèn [229] . Heparinized
and non-heparinized (controls) scaffolds were immersed in 250µl DI water before 500µl
nitrous acid solution (0.025M HNO2, 0.9M HCl) was added and sonicated at RT, to
selectively cleave glucosamine-(1,4)-uronic acid glycosidic bonds of the heparin molecule
to form di/tetrasaccharides. The degradation reaction was stopped after 30 minutes by
the addition of 250µl of ammonium sulfate solution (1M) and vigorously mixed. This
degradation solution was transferred into a clean test tube and the remaining scaffold
was rinsed with 500 µl NaCl solution (1M) which was then added to the degradation
solution. 500µl of MBTH solution (0.011M) was added and reacted with the degraded
heparin at 50◦C for 15 minutes . Subsequently the MBTH molecule was complexed by the
addition of 500µl FeCl3 (9.031 M) solution (50
◦C, 20 minutes) and the resultant solution
was allowed to cool before its absorbance was determined by UV spectroscopy (660 nm,
Shimadzu UV-1601PC).
A standard curve was generated in a similar fashion which differed only in the absence
of a scaffold and the replacement of the 250µl DI water with the same volume of control
solutions of heparin (0 - 2.4mg/ml, 14 points). Scaffold heparin content was determined
using the standard curve and expressed as milligram heparin per gram of scaffold matrix.
3.4 Scaffold Characterisation
3.4.1 Scanning Electron Microscopy (SEM)
Samples were gold sputter coated (Polaron SC7640, Quorum Technologies, East Grin-
stead, England) prior to imaging by SEM. Two different scanning electron microscopes
were used depending on the application: for visualisation of fibre morphology a secondary
scatter mode SEM (Nova NanoSEM 230, FEI, Oregon, USA) was used at an operating
voltage of 20keV; whereas for quantification of fibre morphology and pore-size distri-
bution a backscatter mode desktop SEM (Phenom ProX, Phenom-World, Eindhoven,
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Netherlands) was used at an operating voltage of 10keV. Samples were scanned on both
their luminal and abluminal surfaces.
3.4.2 Fibre Diameter, Alignment & Pore-Size Measurement
Fibre diameter and pore size were automatically quantified with the FiberMetric and
PoroMetric software, respectively (Phenom-World). Image contrast and brightness were
adjusted until only the top-most fibre layer was visible to prevent measurement errors
associated with focal length (see Figure 3.3).
Fibre alignment was characterised using the OrientationJ-Measure plug-in (19.11.2012,
BIG, EPFL, Switzerland [230, 231]) for ImageJ/Fiji (1.49c, NIH, USA [232]) which pro-
duces a ”coherency” value from an image and can be interpreted as the degree of anisotropy
in the scaffold (see Figure 3.4).
(a) Fibre Diameter Measurement (b) Pore Size Measurement
Figure 3.3: Depiction of typical fibre diameter and pore-size measurements using the Phe-
nom FiberMetric and PoroMetric software in a) and b), respectively. Note a) and b) are
taken at different magnifications to improve the accuracy of the automated measurements
.
Figure 3.4: Example of anisotropy determination, the calculated ”coherency” values for
each region are displayed inside the regions boundaries and represent the degree of visual
anisotropy present in the region. The coherency values range from 0 to 1 representing
complete isotropy and anisotropy, respectively. Image adapted from [233]
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3.4.3 Confocal Microscopy
PU and PEO solutions were dyed prior to electrospinning with Fluoroscein Free Acid
(0.2%) and Rhodamine (0.1%), respectively, allowing for visual verification of fibre type
and inter-dispersion. Samples were imaged under confocal laser scanning microscopy
(Zeiss LSM 510 Meta NLO, ZEN 2009 Software, Carl Zeiss Microscopy, Jena, Germany).
3.4.4 Fibre Fraction Determination
Fibre fraction was defined as the percentage PU mass in the scaffold and was determined









Where FFPU is the PU fibre fraction, mPU , mPEO are the mass of PU and PEO present
in the scaffold, respectively and mbefore and mafter are the mass of the scaffold before and
after PEO extraction, respectively.
Mass was determined with a 5 decimal balance (XS105, Mettler-Toledo AG, Greifensee,
Switzerland).
3.4.5 Porosity Determination
Porosity was estimated by gravimetric means using the following equation:
P = 1− Vf
Vb
[%] (3.2)
where P is the calculated porosity, Vb is the bulk volume of the scaffold and Vf is the
volume of the scaffold fibres. The bulk volume (Vb) was calculated by estimating the
scaffold’s boundaries as a rectangular cuboid, where the length and width were mea-
sured with a Vernier Calliper and the thickness was determined with a Leica DFC280
stereo microscope (Leica Microsystems GmbH, Wetzlar, Germany). The fibre volume was
estimated by dividing the mass of the sample post PEO removal (mafter) by the manu-
facturer stated density of Pellethane (ρPU , 1.12 g/ml); where the mass of the sample was
measured on a 5 decimal balance.
Similarly, the porosity of a scaffold before PEO extraction was estimated after its PU
fibre fraction had been calculated (FFPU , Equation 3.1). First, the fibre volume of the
composite scaffold was determined using Equation 3.3, the recorded mass of the sample
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(mbefore) and the manufacturer stated density of PEO (ρPEO, 1.21 g/ml). The calculated
value of Vfb was then used in place of Vf in Equation 3.2 to determine the porosity of the









In order to verify the assumption that the density of the electrospun PU fibres were equiv-
alent to the density of the bulk material, an initial study compared measured porosity
values of 20 samples with various fibre fractions by both gravimetric and densitometric
means. Equivalence was determined with a paired, two-tailed students t-test and setting
the confidence interval (CI) to 90% with a significant mean difference interpreted as a
value greater than 1%.
The densitometric method is similar to the gravimetric method except that the fibre
volume is estimated by Archimedes principle. The scaffold is weighed both in air and while
immersed in liquid (EtOH, ρ = 0,789 g/ml) and the fibre volume calculated according to
equation 3.4 below.




3.4.6 NanoCT 3D Rendering of Scaffold Micro-Architecture
1mm3 cubes of low and high porosity samples (defined in Section 3.6.1.1) were scanned
with a Nanotom S (General Electric, PA, USA) at 500nm voxel resolution and analysed
with VGstudioMax 2.2 (Volume Graphics, Heidelberg, Germany) for determination of
porosity and morphology.
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3.5 Mechanical Testing
All mechanical testing consisted of uni-axially tensile testing specimens until failure on
an Instron 5544 (Instron, Norwood, USA), equipped with a 500N load cell. Samples were
prepared as described in section 3.2.4. Three different groups of mechanical tests were
performed as summarised in Table 3.4.
Table 3.4: Summary of Mechanical Tests Performed on Specimens
Dry @ RT PBS @ 37C
Sac. Fibre
Direction Before After After Hep
Class.
Thick
Circ. 72 52 - -
Trans. 12 8 - -
Thin
Circ. 84 69 45 43
Trans. 23 10 10 13
None
Circ. - 4 4 -
Trans. - 4 4 -
a b c
a) Comparative testing between scaffolds incorporated with thin vs thick sacrificial fibres
- values indicate sample sizes of whole range of fibre fractions (20%-70%) tested per
group, including PEO only (0%, nDCM=4 and nEtOH=4) and PU only (100%, n=4); b)
Assessment of influence of hydration in PBS at 37◦C (100% PU scaffolds only, n=4); c)
Effect of heparinization - range of fibre fractions tested = 20% to 100%.
The effects of PEO incorporation and extraction on scaffold strength were tested dry at
room temperature due to PEO’s rapid dissolution in water. Conversely heparin modified
samples needed to be tested wet due to their hydrogel nature, thus the second set was
tested while immersed in PBS (7.4 pH) at 37◦C, to simulate physiological conditions.
Continuous data sets were analysed by comparing the linear regressions fitted (least
squares) to each group, where the x-axis was set as scaffold fibre fraction or porosity and
the y-axis was the mechanical measurable under observation (UTS, Young’s modulus and
maximum elongation).
Dry samples were tested using standard Instron grips modified with diamond pattern
rubber grip surfaces; while for submerged samples custom made 304 stainless steel grips
were used, also attached with diamond pattern rubber surfaces, see Figure 3.5.
Samples were tested both in the circumferential and transverse direction relative to the
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scaffolds deposition on the collector mandrel in order to quantify the mechanical effects
of fibre alignment (see Figure 3.2c).
Ultimate tensile strength (UTS) and maximum elongation (strain) were obtained from
stress/strain curves and were defined as the stress and strain, respectively at the point
of global maximum stress. Young’s modulus was defined as the slope of the line fitting
the stress/strain data between strains of 0% and 10% (depicted in Figure 3.6).
Figure 3.5: a) Tensile testing in dry conditions, b) Close-up of Instron grips used for dry
testing, c) Tensile testing in PBS-filled water-bath temperature controlled at 37◦C, d)
Custom-made grips for testing under physiological conditions.
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3.5.0.1 Compliance and Burst Pressure Estimation
Theoretical compliance and burst pressure values were calculated for tubular constructs
by transforming tensile testing data using thick walled cylinder theory. Briefly, burst pres-
sure was calculated by assuming the tensile stress in uni-axially extended scaffold sheets
to be equivalent to the hoop stress in cylindrical constructs according to the simplified
version of Lame’s equations (Equation 3.5) which assumes negligible external pressure,
maximum hoop-stress at the inner diameter of the cylinder and negligible radial and axial
stresses and strains. Thick cylinder theory was used because for small diameter grafts







Where σh, Pi, ri and ro are the hoop stress (tensile stress, MPa), internal pressure (MPa),
inner radius (mm) and outer radius (mm) of the theoretical cylinder, respectively. The
UTS of the material (MPa) was then used to determine the maximum internal pressure
responsible for failure which was then converted to mmHg.
In order to calculate diametral compliance, the standard equation was first modified





× 104 [%/100mmHg] (3.6)
Figure 3.6: Typical stress/strain curve showing values definitions for UTS, maximum
elongation and Young’s Modulus.
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Using the definition of strain and converting length (circumference) to equivalent diam-
eter:
Dx = D0(εx + 1) [mm] (3.7)
Substituting 3.7 into 3.6:
Cd =
εs − εd
(Ps − Pd)(εd + 1)
× 104 [%/100mmHg] (3.8)
Where Cd, Ds and Dd are diametral compliance, diameter of the imaginary graft at systole
and diastole. Additionally, Dx is the equivalent diameter of the conduit at a given strain
(εx). σs, σd and εs, εd are the equivalent hoop stresses and strains at systolic and diastolic
pressures, respectively.
Now, by determining the equivalent hoop stress (Equation 3.5) at 80mmHg (Pd, 1.07 ×
10−2 MPa) and 120mmHg (Ps, 1.60 × 10−2 MPa) internal pressures, the corresponding
strain values were read off of the stress/strain curve, which was previously obtained
from uni-axial testing (see Figure 3.7). Utilizing these strain values in Equation 3.8
a theoretical diametral compliance could be calculated for each sample that had been
uni-axially tested.
Compliance was calculated for theoretical grafts 0.5mm thick with internal diameters of
6mm for PU and PU+Hep at physiological conditions (PBS at 37◦C).
3.5.1 Strain Rate Calculations
In order to simulate the physiological conditions that the material would undergo as
a vascular graft an ideal strain rate was calculated using healthy blood vessels as a
reference: The average compliance of a healthy blood vessel was estimated by Tai et
al [106] to be 8%/100mmHg, equating to 3.2%/40mmHg for a healthy 120/80mmHg
blood pressure. The 40mmHg pulsatile pressure is experienced over the systolic ejection
period of the cardiac cycle, which is dependant on heart rate (HR) and, according to
Weissler et al [234], can be calculated using the following equation:
tsystole = 0.413− 0.0017×HR [s] (3.9)
Assuming a healthy average HR of 72bpm [235] the systolic period is approximately
290ms.
Thus an ideal blood vessel would experience a compliance of 3.2% over a duration of
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Figure 3.7: Calculation of compliance, first equivalent hoop stresses calculated for internal
systolic and diastolic pressures, this is assumed to be equivalent to the tensile stress
observed in uni-axially extended samples. The strain at the resultant stresses from systolic
and diastolic pressures are then obtained from the stress/strain curve which can then be
used to calculate compliance with Equation 3.8.




Thus, for the chosen gauge length of 10mm, the strain rate was set to 1.1mm/sec.
3.6 In Vivo Subcutaneous Study
All animal experiments performed in this thesis were in compliance with the Animal
Protection Act (Act 71 of 1962), the Veterinary and Paraveterinary Professions Act (Act
19 of 1982) and the South African National Standard for the Care and Use of Animals
for Scientific Purpose (SANS 10386:2008), and were approved by the Departmental Re-
search Committee and Animal Ethics Committee of the University of Cape Town before
commencement.
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3.6.1 Experimental Design
Scaffolds of three different porosity classes (low, medium and high) and their heparinized
versions were assessed for tissue ingrowth, inflammation and angiogenesis through dorsal
subcutaneous implantation in male Wistar rats (250g - 300g).
In order to detect a mean difference of 10% between groups with a standard deviation of
5% within each group a sample size of 6 was calculated (α = 0.05 (one-tailed); β = 0, 9)
with StatsMate (StatsMate 2.00, GraphPad,CA,USA). In order to determine differences
in the rate of tissue ingrowth, vascularization and inflammation between samples, three
different time points were investigated: 7, 14 and 28 days. Figure 3.8 below summarises
the experiment graphically.
(a) Dorsal View (Adapted from [22]) (b) Experiment Flow Chart
Figure 3.8: Scaffolds of different porosity classes (High/Medium/Low) and heperanised
versions (High-Hep/Medium-Hep/Low-Hep) of each (6 total), prepared as described in
section 3.2.4, were subcutaneously implanted into dorsal pockets of male Wistar rats
(250g - 300g) for three different durations (7, 14 and 28 days) with a sample size of 6 per
time point (totalling 18 rats). Sample locations were rotated between rats to compensate
for anatomical variation.
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3.6.1.1 Scaffold Fabrication
Low, medium and high porosity scaffolds were defined as those with porosities of 70%,
80% and 90%, equating to PU fibre fractions of 100%, 70% and 30%, respectively (when
estimated from Figure 4.11 in Section 4.2.5).
Fibre fraction was controlled by varying the PEO solution flow rate according to values
calculated by Equation 3.12 below; where η, ρ, C and Q represent the electrospinning
efficiency constant, density, concentration and flow rate, respectively of each solution. η
can be estimated empirically with Equation 3.11, where t is the spinning duration and
mloss is the mass of polymer that was spun but did not deposit in the scaffold region. η















For low porosity scaffolds, a second PU solution was spun in place of the PEO solution
at 3ml/hr to simulate the inter-fibre forces present with the medium and high porosity
scaffolds. Scaffolds were then prepared as described in section 3.2.4, dried by lyophiliza-
tion and their fibre fractions and porosities determined as described in sections 3.4.4 and
3.4.5, respectively. Heparinized versions were then prepared as described in section 3.3.
3.6.2 Surgical Procedures
Animals were allowed to acclimatize in their groups (6 per cage) and surroundings for 2
days pre-operatively and were fed ad libitum throughout the experiment. Prior to surgery
rats were weighed, placed under general anaesthesia through inhalation of 5% isoflurane in
an enclosed perspex box (equipped with disposable absorbent pads), dorsally shaved and
the surgical area disinfected with consecutive swabbing of F10 Skin Prep, 70% Alcohol
and finally Iodine solution. At this point buprenorphine (0.05mg/kg) was administered
subcutaneously for post surgical analgesia. The animals were then placed on a tem-
perature controlled (37◦C) operating board where general anaesthesia was maintained
through nose-cone inhalation of 1.5% isoflurane at an oxygen output of 1.5l/min (1 Bar,
21◦C). Surgery was performed under sterile conditions, inside a laminar flow hood.
Prior to incision, appropriate depth of anaesthesia was verified by lack of limb reflex on
stimulation. Following sterile draping 1 cm incisions were made bi-laterally with respect
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to the dorsal mid-line and pockets opened laterally using blunt dissection, while paying
close attention to prevent communication with adjacent pockets. Scaffolds, which had
previously been sterilized with Ethylene Oxide (EO) and stored in sterile PBS (7.4pH),
were then placed in the pockets in a rotationally varied order and resealed with 2/0
Monofilament Nylon sutures (Ethilon, Ethicon, New Brunswick, NJ). After all 6 pockets
had been resealed, rats were marked for identification with an ear punch (while still under
general anaesthesia).
Rats were then placed under a warming lamp and monitored until fully conscious. Fol-
lowing surgery, animals were housed individually for 4 days, weighed every second day
and monitored daily during that time, on the first day post surgery rats were adminis-
tered with a second dose of 0.05mg/kg buprenorphine subcutaneously. After 4 days the
rats were reintroduced to their original groups of 6 per cage and were monitored daily
and weighed weekly thereafter.
Scaffolds were explanted with surrounding skin and fibrous capsule at 7,14 and 28 days
after euthanasia by inhalation of 5% halothane in air. Death was confirmed by cardiac
injection of 1 ml saturated KCl solution. Samples were cut in half using a sharp blade
where one half was placed in Zinc fixative solution [236] and the other half in 10%
Formalin.
3.6.3 Histological Analysis
After 4 days of fixation samples were dehydrated by immersion in ascending grades of al-
cohol, embedded in wax, cut into 5µm sections, mounted onto slides and de-waxed using
2,2,4-trimethylpentane followed by hydration in descending grades of alcohol. Sections
were then stained with Haematoxylin and Eosin (HE) to characterise tissue colonization;
Picroserius Red (PSR) to quantify collagen deposition; anti-CD31 (Fitzgerald Interna-
tional, North Acton, MA) to label endothelial cells for visualisation of angiogenesis; and
anti-ED1 (Serotec Ltd, Oxford, UK) (Cy3 secondary antibody) counter stained with 4’,6-
diamidino-2-phenylindole (DAPI) for identification of tissue macrophages. Histological
preparation of samples was performed in-house by the histology group of the Cardiovas-
cular Research Unit.
Sections were imaged in cross-section (Nikon Eclipse 90i, Nikon, Tokyo, Japan) and
stitched at appropriate magnifications (H&E = 2X, PSR = 4X, CD31 = 10X and ED1 =
20X) to include the visible graft area. All slides were imaged under bright-field microscopy
except for ED1 slides (fluorescent microscopy). Captured images were processed for
quantitative analysis using Visiopharm Integrated Systems (Visiopharm A/S, Hørsholm,
Denmark).
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Ingrowth index was defined as the average distance perpendicular to the graft edge where
gross infiltration had occurred divided by half the scaffold width and was calculated,
assuming a rectangular cross section, according to Ingrowth Index = 2dt/ws where dt
and ws represent the average tissue infiltration depth and scaffold width, respectively.
Isolated cells, populating deeper regions of the scaffold away from the majority of the
population, are excluded (n=6).
























Figure 3.9: Graphical depiction of average ingrowth determination: image segmented,
isolated cells excluded and average infiltration depth determined from the territory gained
by the bulk of the tissue ingrowth.
Collagen fraction was defined as the area of collagen detected within the scaffold bound-
aries divided by the total scaffold area. An ingrowth adjusted index value was calculated
as the absolute collagen value divided by the calculated ingrowth area from H&E stained
slides (n=6).
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Vascularisation was assessed by normalising the count of vessels by the total scaffold area
and then scaling to density per mm2 (Vessel density/mm2). Half of each scaffold was
imaged to reduce computational processing requirements (n=6).
Inflammatory response was assessed by dividing the total area of ED1 positive structures
by the total scaffold area visible in the image (ED1 Positive Index). Nine fields (3x3) of
one of the corners (to reduce computational strain when segmenting the image) of each
scaffold was imaged at a magnification of 20X for each sample (7 & 14 days → n=2, 28
days → n=6).
3.7 Statistical Analysis
Statistical tests were performed with GraphPad Prism 6.05 (GraphPad Software, San
Diego, CA) and differences were considered statistically significant for p-values of 0.05 or
less. All data are expressed as means ± standard deviation of the mean unless otherwise
stated. For multiple comparisons a two-way ANOVA test was performed and when sig-
nificance was detected, multiple comparisons were executed with Tukey’s test for P-value
correction (unless otherwise stated). For single comparisons a two-tailed students t-test
was performed (paired/unpaired depending on the application).
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Chapter 4
Results
This chapter will proceed to state the results observed during this thesis which will then
be discussed in Chapter 5. The results of the single spinneret electrospinning experiments,
which formed a foundation for the rest of the thesis, will be described first in Section 4.1;
followed by the results of the dual electrospinning experiments in Section 4.2. Qualitative
and quantitative results obtained from the heparin surface modification will then be
discussed in Section 4.3 and finally the in vivo subcutaneous rat study results will be
discussed in Section 4.4.
4.1 Single Spinneret Electrospinning
Firstly, the PU solvent system comparison will be presented followed by a PEO fibre
diameter analysis, which links with the sacrifical fibre analysis section described later
(Section 4.2).
4.1.1 Polyurethane Fibre Optimization
No differences in fibre diameter or alignment were observed between luminal and ablumi-
nal surfaces for both PU/THF and PU/THF:DMF (p>0.5). However the PU/THF:DMF
group resulted in smaller fibre diameters (p<0.01) and more isotropic fibre deposition
(p<0.0001) than PU/THF. Besides morphological characteristics, it was observed that
deposition occurred over larger area (along the transverse axis) of the collector mandrel
for PU/THF:DMF (± 120mm vs ± 60mm) than PU/THF. The stable region of the fi-
brous jet was distinctly shorter for the THF:DMF group and its whipping radius much
larger than for THF group. Figure 4.1 and Figure 4.2 depict SEM micrographs and an
analysis of the two groups respectively.
57
University of Cape Town Department of Biomedical Engineering










Figure 4.1: SEM images of the resultant fibrous structures of each solvent system. All
images have been acquired at the same maginification and scale bars represent 50µm
Figure 4.2: Comparison of morphological characteristics resulting from different PU sol-
vent systems: a) Fibre diameter and b) Fibre alignment. c) THF:DMF resulted in a
wider deposition band on the mandrel. *Denotes statistical significance between groups,
p<0.05 (n=2)
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4.1.2 PEO Fibre Diameter Analysis
PEO/DCM and PEO/EtOH were spun individually at 2 ml/hr, 4 ml/hr and 6 ml/hr
and the resultant fibre diameters of each group compared. PEO/DCM required constant
monitoring as excessive evaporation of the solvent at the capillary tip would result in
blockage, requiring manual intervention to remove the blockages. This was not the case for
PEO/EtOH, which additionally deposited over a much wider area (transverse direction)
of the mandrel than PEO/DCM (±120mm vs ±40mm) and had a larger whipping radius.
When PEO/DCM was spun at 6ml/hr the solvent did not evaporate sufficiently before
deposition, resulting in a solid film structure on the luminal surface of the graft. When
the capillary to collector distance was increased (>10cm) then the Taylor cone would
erratically cease to form and interrupt jet formation.
On average, for all flow rates, PEO/DCM resulted in significantly larger fibre diameters
than PEO/EtOH (mean difference = 6.2µm, p<0.0001). The effect of flow rate on fibre
diameter differed between the two solvents where fibre diameter increased with increas-
ing flow rates for PEO/DCM (p<0.001) but almost no differences were observed in fibre
diameter across flow rates for PEO/EtOH (See Figure 4.3). PEO/DCM fibres were also
observed to be non-uniform with many smaller diameter fibres ejecting perpendicularly
from the primary, large diameter fibres. The small sample size (n=2) used in this pre-
liminary study imposes limits on the conclusions that can be drawn about the effect of
solution flow rate on fibre diameter. However, on average for all flow rates, it can be seen
that fibres spun from PEO/DCM produced larger fibres on average than when spun from
PEO/EtOH.
Figure 4.3: Effect of flow rate on fibre diameter for DCM (note: Luminal surface at
6ml/hr formed a film) and EtOH. *p<0.05; **p<0.001. (n=2)
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Figure 4.4: SEM images of the resultant fibrous structures (abluminal surface) for each
solvent system and flow rate (FR). Scale bars represent 50µm
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4.1.2.1 Effect of Flow Rate on PEO Mechanical Properties
Increases in PEO solution flow rate were found to cause increases in UTS (p<0.0001)
and Young’s modulus (p<0.0001) but decreases in the maximum elongation (p<0.0001)
of 100% PEO scaffolds, for either DCM or EtOH solvents (Figure 4.5). However, for
PEO/EtOH (thin), significant differences in mechanical properties were only observed
between flow rates of 2 ml/hr and 4 ml/hr (p<0.001) but not 4 ml/hr and 6 ml/hr
(p>0.74). PEO/DCM (thick) samples spun at solution flow rates of 6 ml/hr became
brittle after removal from the mandrel and snapped during the sample preparation pro-
cess. PEO/DCM produced scaffolds which were stronger (p<0.01), stiffer (p<0.0001) but
endured less strain before failure (p<0.0001) than PEO/EtOH on average across solution
flow rates.
Figure 4.5: Effect of flow rate and solvent system on scaffold mechanical properties. Note:
DCM at 6 ml/hr samples snapped during preparation process. All groups significantly
different from one another (p<0.05, n=4) except for groups joined with a solid line.
4.2 Dual Electrospinning with Sacrificial Fibres
This section describes the results of dual-spinning PU with PEO as a sacrificial fibre.
First the results of the electric field design experiments will be presented in Section 4.2.1
followed an assessment of the PEO extraction and drying process (Section 4.2.2) as well
as verification of the porosity determination method (Section 4.2.3). Visualisation of the
sacrificial fibre inclusion and removal will then be presented followed by an analysis of
the relationship between scaffold fibre fraction, sacrificial fibre size and porosity. Note,
the analysis of PEO fibre diameter was provided previously in Section 4.1.2.
Chapter 4: Results 61
University of Cape Town Department of Biomedical Engineering
4.2.1 Tailoring the Electric Field
Table 4.1 provides a summary of the results of different electrospinning configurations
tested. Briefly, opposite polarity spinnerets created oppositely charged fibrous jets which
resulted in a net attractive force between the two jets. For large collector mandrels
(Figure 4.1.A.1) the jets deposited uniformly in an inter-dispersed manner in the mid-
dle (transverse direction) of the collector; however, for small collector mandrels (Figure
4.1.A.2) the jets collided in mid-air and little-to-no deposition occurred on the collector.
Conversely, like charged spinnerets resulted in a net repulsive force between the two jets.
Both jets deposited efficiently on both the small and large collector mandrel however two
distinct populations were apparent over the length of the mandrel (transverse direction,
Figure 4.1.B.1). When charged electro-static shields (same polarity as spinnerets) were
placed on either side of the collector (Figure 4.1.B.2) the inter-dispersion between the
two fibre types was improved. By slightly charging the collector (|<2kV|, high voltages
resulted in arcing to the electric motor circuit) in the opposite polarity to the spinnerets
the inter-dispersion of the two fibre types was further improved (Figure 4.1.B.3).
Table 4.1: Electric Field Configurations Tested
Description Diagram Electric Field
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Description Diagram Electric Field
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Electric Field column: blue, red, green represent positively charged, negatively charged and
grounded objects, respectively, while cyan represent positively charged objects with potentials
independant of blue objects. Note, type B.1 & B.2 configurations were tested with reverse
polarities as well. Electric field simulations generated from [237].
4.2.2 PEO Extraction & Drying Process
Vacuum drying and freeze-drying were both tested as suitable methods of drying the
grafts post PEO extraction. While no significant difference in shrinkage between methods
was observed for 100% fibre fraction grafts (p=0.5); vacuum drying resulted in more
Chapter 4: Results 63
University of Cape Town Department of Biomedical Engineering
shrinkage for 70% (54% vs 40% shrinkage, p<0.05) and 30% (62% vs 34% shrinkage,
p<0.01) fibre fraction grafts than freeze drying. Figure 4.6 summarises the results of the
study graphically.
Figure 4.6: The effect of the drying
process used is dependant on the fibre
fraction of the graft, where high and
low fibre fraction grafts are least and
most affected by drying process, respec-
tively (interaction: p <0.05, Two-way
ANOVA). *Denotes statistically signifi-
cant from other groups, p<0.05 (n=2).
No adjustment for multiple comparisons.
4.2.3 Porosity Determination
No difference was observed between porosity measurements calculated by gravimetric
and densitometric means (mean difference = 0.05%, p> 0.9). Figure 4.7 illustrates the
calculated values from each method graphically.
Figure 4.7: Plot of individual samples
showing measured value for gravimet-
ric and densitometric techniques. No
statistical significance found between
means, mean difference = 0.05%, CI =
90%, p>0.9
Chapter 4: Results 64
University of Cape Town Department of Biomedical Engineering
4.2.4 Visualisation of PEO Fibre Inclusion and Removal
The inclusion of distinct sacrificial fibre diameters was verified by incorporation of fluores-
cent dyes into the polymer solutions before electrospinning and imaging under fluorescent
microscopy after. Figure 4.8 depicts the inclusion of both thick (a) and thin (b) PEO
fibres. Both the PEO and PU fibres exhibited autofluorescence in the same bandwidth
as Rhodamine (∼627nm, red) and Fluoroscein (∼515nm, green) but at lower intensities
than fluorescently dyed fibres (thick PEO fibres are still observed to autofluorescence in
the green channel). Scaffolds imaged post-PEO removal detected only autofluorescence
in either the green or red channel indicating the removal of the dyes during the PEO
removal process (image not shown).
SEM images taken before and after PEO-removal (Figure 4.9) show the resultant differ-
ences in packing density and pore-size achieved for 30% fibre fraction scaffolds using thin
and thick sacrificial fibres. A 100% fibre fraction PU control was imaged before and after
undergoing the the same process as used for PEO extraction, exhibiting no difference
in morphology or fibre density (full pore-size and porosity quantification is provided in
section 4.2.5).
(a) PU + PEO/DCM (Thick) (b) PU + PEO/EtOH (Thin)
(c) PU (d) PEO/DCM (e) PEO/EtOH
Figure 4.8: Confocal images of scaffolds with the inclusion of thick (a) and thin (b) sacrificial fibres.
c-e: Control stains of PEO (Rhodamine, red) or PU (Fluoroscein, green). Scale bars = 50µm
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Figure 4.9: SEM images before and after removal of thick (PEO/DCM) and thin
(PEO/EtOH) sacrificial fibres, observe the increase in pore-size between groups where
sacrificial fibres had been included. 100% PU scaffolds subjected to the same extraction
process show no discernible difference. Scale bars represent 50µm
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Side section SEM images detail the morphological differences between scaffolds produced
with thick, thin and no sacrificial fibres post PEO removal, where thick type scaffolds
produced evidence of laminated rather than inter-dispersed fibre deposition. Laminated
fibre deposition, where each material is sequentially spun onto an area rather than simul-
taneously, exhibits large flattened void spaces between dense PU sheets (Figure 4.10a &
4.10d) instead of increasing fibre-to-fibre distance uniformly between individual PU fibres
(Figure 4.10b).
(a) PU + PEO/DCM (b) PU + PEO/EtOH
(c) PU - Control (d) Severe Lamination
Figure 4.10: Side-section SEM images of scaffolds post-PEO removal process with a)
thick sacrificial, b) thin sacrificial and c) no sacrificial (control) fibres depicting effects
of inter-dispersion of sacrificial and structural fibres on resultant scaffold morphology. d)
Pronounced example of laminate instead of inter-dispersed fibre deposition showing gaps
where PEO has been removed between dense layers of PU. Scale bars represent 100µm
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4.2.5 Effect on Porosity
Porosity increased linearly with decreasing PU fibre fractions for scaffolds spun with thick
(P = −0.18FF+89.1, r2=0.84) and thin (P = −0.18FF+93.5, r2=0.91) sacrificial fibres,
where both lines shared a common (m = 0.18, p=0.85), non-zero (p<0.0001) slope but
differed in their y-intercepts with thin sacrificial fibre type scaffolds being more porous
by 4.4% (p<0.0001).
Figure 4.11: Linear regression of fibre fraction and porosity for PEO/DCM and
PEO/EtOH. Common slopes (p=0.85) significantly non-zero (p<0.0001) but differ in
their y-intercepts (p<0.0001)
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Porosity was calculated before and after PEO removal for thin, thick and no sacrificial
fibre groups and compared by means of a repeated measures two-way ANOVA. No differ-
ences in porosity were observed between groups before PEO removal (p>0.38); however,
after removal thick and thin groups increased in porosity by 19% and 21% (p<0.0001),
respectively, whereas the control group was unaffected by the PEO removal process
(p>0.9999). Thick and thin groups, post PEO removal, were more porous than the
control group by 15% and 19%, respectively (p<0.0001). See Figure 4.12.
Using the recorded bulk volume values before and after PEO removal for each sample
an index for bulk volume reduction (shrinkage) could be obtained. It was observed that
thick sacrificial fibre groups suffered greater shrinkage than thin (mean difference = 21%,
p<0.0001) and control groups (mean difference = 31%, p<0.01). See Figure 4.12b below.
Figure 4.12: a) Mean effects of sacrificial fibre diameter on scaffold porosity both before
and after removal, * p<0.001. b) PEO/DCM scaffolds experienced severe reductions in
bulk volume loss, ** p<0.01.
4.2.6 Effect on PU Morphology
Post PEO removal, scaffolds fabricated with the inclusion of thin sacrificial fibres ap-
peared slightly less aligned than 100% PU scaffolds (anisotropy index = 0.20±0.09 vs
0.38±0.06, p=0.002). However, no significant differences were observed in alignment
between thick and thin (p=0.13) or thick and 100%PU groups (p=0.07, Figure 4.13a).
The addition and subsequent removal of thick and thin sacrificial fibres did not result
in significant changes to fibre diameter when compared to 100% PU scaffolds (p=0.42,
One-way ANOVA, Figure 4.13b)
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Figure 4.13: Effects of sacrificial fibre diameter on the a) alignment and b) diameter of
the remaining PU fibres post PEO removal, * p<0.05.
4.2.7 Mechanical Properties
In an effort to improve the readability of this section, analysis of the mechanical testing
data will be split into three parts: firstly, the mechanical effects of the inclusion and sub-
sequent removal of sacrificial fibres will be detailed for thin (PEO/EtOH) sacrificial fibres
only (Section 4.2.7.1); next, a comparison of thin and thick (PEO/DCM) sacrificial fibre
type scaffolds will be provided (Section 4.2.7.2) and finally the effects of environmental
conditions on the mechanical properties 100% PU constructs will be investigated (Section
4.2.7.3).
4.2.7.1 Effect of Sacrificial Fibre Inclusion and Removal
Figure 4.15 summarises the difference in mechanical properties between scaffolds compris-
ing 100% PEO, 100% PU and a 30%/70% (PU/PEO) composite both before and after
PEO removal. Note that all tests were conducted dry at room temperature to facilitate
the testing of 100% PEO scaffolds which could not be tested in simulated physiological
conditions due to PEO’s rapid dissolution in aqueous solutions.
Circumferentially oriented (CD) samples possessed greater ultimate tensile stresses (UTS)
than transversely oriented (TD) samples across all groups (p<0.01); however, TD samples
were able to undergo greater elongations before failure for all groups (p<0.005). The
effects of orientation on Young’s modulus were not consistent across all groups where
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PEO and PU/PEO (before PEO removal) groups were more rigid in the circumferential
than in the transverse direction (p<0.0001) but no significant differences were noted
between orientations for PU and PU/PEO (after PEO removal) groups (p>0.9).
Pure PU scaffolds which had undergone the PEO removal process differed, versus PU
scaffolds that had not, only in their maximum elongation before failure where the mean
differences in the circumferential and transverse direction were 85% (p<0.001) and 132%
(p<0.0001), respectively. The UTS and Young’s modulus of the pure PU scaffolds were
unaffected by the PEO removal process (p>0.05).
Before PEO removal (CD), PU/PEO samples exhibited intermediary properties between
pure scaffolds of each polymer. Post PEO removal the composite scaffolds were found
have lower UTS values (p<0.0001), failed at lesser strains (p<0.0001) and had non-
significantly lower Young’s moduli (p=0.4) than pure PU scaffolds which had undergone
the same PEO removal process.
PEO groups were more rigid (22.4 MPa vs 3.2 MPa, p<0.0001) but endured lesser max-
imum elongations (40% vs 533%, p<0.0001) than PU groups. PU samples were far
stronger than PEO samples with UTS values approximately 4 times greater (p<0.0001).
Figure 4.14: Typical stress/strain curves per group, note the steep elastic region on PEO
and PU/PEO samples before PEO removal. Curves depict circumferentially oriented
samples only.
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Figure 4.15: Mechanical properties of 100% PEO, 30%PU+PEO/EtOH and 100% PU
constructs showing influence of sacrificial fibre before and after its removal on: a) ul-
timate tensile strength (UTS), b) Young’s modulus and c) maximum elongation before
failure. *Denotes significance between groups with p<0.05, Two-way ANOVA followed
by uncorrected multiple comparisons.
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4.2.7.2 Comparison of Thin vs Thick Sacrificial Fibres
Scaffolds of a range of fibre fractions (15% - 70%) were spun with either thick or thin
sacrificial fibres and compared by means of linear regression both before and after PEO
extraction. Figure 4.16 summarises the information obtained from the experiment but a
detailed analysis is provided below.
Before PEO extraction the UTS of thin groups increased linearly (84±16 kPa/%PU, r2
= 0.77, p<0.001) with increasing PU fibre fractions while an opposite effect was noted
for thick groups, where slight decreases, and a weaker correlation, were noted in UTS for
increasing fibre fractions (-42±16 kPa/%PU, r2 = 0.46, p<0.05). No significant difference
(p=0.06, common line: E = 31.4 − 0.38FF MPa) was observed between groups for
Young’s modulus where scaffold stiffness decreased linearly, with increasing fibre fractions,
for both thin (r2 = 0.90, p<0.0001) and thick (r2 = 0.72, p<0.001) groups. Little-to-no
correlation was observed between fibre fraction and maximum elongation for thin (r2 =
0.52, p=0.01) and thick (r2 = 0.004, p=0.9), however thick groups endured significantly
more strain before failure than thin groups (214% ± 21%, p<0.0001).
After PEO extraction similar slopes, but different elevations were observed between
groups in all measures with thick groups consistently exhibiting greater values (p<0.0001)
for all. A linear relationship was observed between fibre fraction and UTS (thin: 69±12
kPa/%PU, r2 = 0.78, p<0.001; thick: 86±20 kPa/%PU, r2 = 0.71, p<0.01) and Young’s
modulus (thin: 17±2 kPa/%PU, r2 = 0.91, p<0.0001; thick: 22±4 kPa/%PU, r2 = 0.80,
p<0.001) but correlation was weak between fibre fraction and maximum elongation (thin:
r2 = 0.61, p<0.01; thick: r2 = 0.06, p = 0.5).
When all measures, post PEO removal, were plotted with porosity as the x-axis, in
place of fibre fraction, improved r2 values were obtained for all line fits (excluding the
thin group for Young’s Modulus). Additionally, when compared with porosity on the
x-axis it was found that thin and thick groups shared a common line for UTS (p=0.1,
UTS = −0.32P + 32 MPa) and Young’s modulus (p=0.5, E = −0.08P + 7.9 MPa). The
fits for maximum elongation, while improved over fibre fraction as an x-axis, were still
weak with r2 values of 0.48 and 0.62 for thick and thin groups, respectively; however,
thick groups were observed to stretch more before failure than their thin counterparts
(mean difference = 156%±19%, p<0.001)
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Figure 4.16: Comparison of constructs fabricated with thin (n=44) and thick (n=43)
sacrificial fibres both before and after PEO removal. Thick groups compared on the
fibre fraction axis consistently exhibit superior mechanical properties than their thin
counterparts; however when compared on the porosity axis, both are equivalent in their
mechanical properties except for maximum elongation. Note that y-axis scales for Young’s
Modulus are different between “Before” and “After” graphs. “Sig.” denotes non-zero
significance of fitted slopes. “Diff.” expresses the difference between fitted slopes.
Chapter 4: Results 74
University of Cape Town Department of Biomedical Engineering
4.2.7.3 Effect of Testing Conditions on Scaffold Strength
No significant differences in UTS, Young’s modulus and maximum elongation were found
between “wet” and “dry” groups in the circumferential orientation (p>0.06). How-
ever, in transversely oriented groups small but significant increases in Young’s modu-
lus (0.65±0.03 vs 0.24±0.06 MPa, p<0.0001) and maximum elongation (497±35% vs
426±13%, p<0.01) were observed when tested in physiological conditions compared to
dry at room temperature. Figure 4.17
Figure 4.17: Effect of physiological conditions on PU scaffolds (n=4). *p<0.0001,
**p<0.01. RT = 22◦±2◦C. Water bath maintained at 37◦±1◦C
4.3 Heparin Surface Modification
This section provides details of the qualitative and quantitative verifications and effects
of the heparin surface modification. Note that going forward thin type (PEO/EtOH)
sacrificial fibres had been selected for further study due to their ability to produce higher
porosity constructs and so thick type (PEO/DCM) composites were not studied further.
Qualitative and quantitative measures of heparinization efficacy are initially provided in
Section 4.3.1 and 4.3.2, respectively. The effects of the heparinization process on the
scaffold morphology are then presented in Section 4.3.3 followed by an analysis of the
effects on scaffold mechanical properties in Section 4.3.4
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4.3.1 Qualitative Results
Figure 4.18 depicts the results of the heparin binding verification assay.
Figure 4.18: Qualitative verification of heparinization:
PU controls were not stained by either Ponceau S (PS)
or Toluidine Blue (TB). Samples that had undergone
the acrylic acid grafting step were dyed blue by TB in-
dicating the presence of negatively charged carboxyl
groups. After the amination process samples were
stained red by PS, and were no longer stained by TB,
indicating the presence of positively charged amines
and depletion of carboxyls, respectively. Finally, af-
ter heparinization the samples stained bright purple by
TB and were no longer stained by PS, indicating the
presence of highly negatively charged heparin molecules
and depletion of amines on the surface of the fibres, re-
spectively.
4.3.2 Quantitative Results
Scaffolds of a range of fibre fractions (20% - 100%), heparinized for mechanical testing,
were also analysed for heparin content by MBTH assay, Figure 4.19 below summarises the
data obtained from the experiment. No correlation was noted between heparin content
and fibre fraction (r = -0.4, p = 0.25) and thus an average heparin content could be
calculated per sample, after deducting the background reading (control values), to be
7.5±0.7 mg/g.
Figure 4.19: Quantitative assess-
ment of heparinization: signif-
icantly more (p<0.0001) hep-
arin detected per unit mass in
heparinized groups than control
groups. No significant differ-
ences detected across fibre frac-
tions (p=0.66, n = 3). Mean
heparin content = 7.5±0.7 mg/g.
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4.3.3 Visualisation of Heparin Hydrogel Grafting
Figure 4.20 provides SEM images of samples before and after the heparinization process,
note the “cobblestone” appearance of the dehydrated (in order obtain SEM images)
heparin hydrogel layer on the surface of the PU fibres. A full study of the effects of the
heparinization process on scaffold morphology will be described in Section 4.4.1.
(a) PU (b) PU-HEP
Figure 4.20: SEM images of PU surface before and after the heparinization process. Scale
bars represent 5µm
4.3.4 Effect on Mechanical Properties
Figure 4.21 and 4.22 provide typical stress/strain curves (circumferential direction) and
summaries of the experiment’s results, respectively.
The effect of the heparinization process on scaffold strength was observed to be depen-
dant on the fibre fraction of the scaffold for both CD and TD groups, where the slopes
were significantly different (p<0.0001) between heparinized and non-heparinized groups.
The effect was most pronounced in the circumferential direction where 100% PU samples
endured decreases of 7.6±0.8 MPa versus 2.5±0.6 MPa for 30% PU samples. For hep-
arinized samples in the transverse direction, strength was not observed to be dependant
on fibre fraction (m = 0.002±0.001 MPa/PU%, r2 = 0.21, p=0.11).
Heparinized constructs were observed to be slightly more rigid in both the circumferential
(p<0.0001) and transverse (p<0.01) directions than their non-heparinized counterparts
with statistically parallel but distinct fitted lines. Slopes for CD (r2 = 0.79 (PU) / 0.39
(Hep), p<0.0001) and TD groups (r2 = 0.75 (PU) / 0.73 (Hep) ,p<0.001) were found to
increase linearly with increases in fibre fraction.
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The relationship between maximum strain and fibre fraction for heparinized and non-
heparinized samples was not well described with the linear regression and no depen-
dency was observed (r2 <0.09, p>0.37); except for transversely oriented heparinized
samples where maximum elongation was observed to decrease linearly with increasing
fibre fractions (r2 = 0.82, p<0.0001). Non-heparinized samples consistently endured
greater strains than their heparinized counterparts with mean differences of 337%±24%
(p<0.0001) and 366%±48% (p<0.0001) in the circumferential and transverse directions,
respectively. Note that in the transverse direction the difference in maximum elongation
between groups increased with increasing fibre fractions (p<0.0001).
Figure 4.21: Typical stress/strain curves for heparinized and non-heparinized constructs.
Note the decrease in maximum strain as well as UTS for pure PU samples, PU/PEO
(45% fibre fraction, PEO removed) does not exhibit such large UTS losses.
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Figure 4.22: Mechanical effects of heparin surface modification process. Total sample
sizes per group were: nCD=45 and nTD=10 for Non-Hep and nCD=42 and nTD=13)
for Hep groups in the circumferential and transverse orientations, respectively. “Sig.”
denotes non-zero significance of fitted slopes. “Diff.” expresses the difference between
fitted slopes.
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4.3.5 Compliance and Burst Pressure
Tensile testing data from Section 4.3.4 was transformed into equivalent theoretical burst
pressures and compliance values for 6mm diameter, 0.5mm thick vascular grafts. Figure
4.23 depicts the results of the transformation. Compliance was calculated to linearly
decrease with increasing fibre fractions for both PU (Cd = −0.078± 0.015FFPU + 10.3±
0.92 %/100mmHg, r2 = 0.72, p<0.001) and PU+Hep (Cd = −0.038±0.016FFPU +6.93±
0.98 %/100mmHg, r2 = 0.45, p<0.05) where the slope of the PU line was steeper than
the PU+Hep line (p=0.0025)
Burst pressure was calculated to increase linearly with increasing fibre fraction for PU
(BP = 76 ± 13FFPU + 1443 ± 775 mmHg, r2 = 0.74, p<0.0001) and PU+Hep (BP =
33± 5FFPU − 87± 312 mmHg, r2 = 0.83, p=0.0002) where the slope of the PU line was
steeper than the PU+Hep line (p<0.0001)
Figure 4.23: Calculated compliance and burst pressures of 6mm diameter, 0.5mm thick
imaginary constructs. Compliance was observed to decrease linearly with increasing
fibre fractions and heparinized constructs were less compliant than their non-heparinized
counterparts at low fibre fractions. Burst pressures were observed to increase linearly
with fibre fraction for both groups although heparinized groups were consistently weaker.
PA 30 and PA 70 are compliance values of the human popliteal artery measured in
patients at ages of 29±4 and 69±10 years of age, respectively [102]. Artery refers to the
minimum burst pressure of 2000mmHg commonly sought in literature [127,238,239]
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4.4 In Vivo Subcutaneous Study
This section provides details on the results of the in Vivo subcutaneous rat study investi-
gating the effect of porosity and the heparin surface modification on tissue ingrowth, col-
lagen deposition, vascularisation and inflammatory response. Firstly, the scaffold groups
implanted were analysed for porosity, fibre diameter and pore-size prior to implantation
in Section 4.4.1 followed by a full histological analyses post explanation in Section 4.4.2.
All animals survived until their scheduled explant time.
4.4.1 Scaffold Morphology
Low, medium and high porosity scaffolds, along with heparinized (Hep) versions of each
were analysed for fibre diameter, fibre alignment, pore-size, porosity and scaffold thick-
ness. Figure 4.24 provides typical SEM images of each group and Figure 4.25 summarises
the results of their analyses graphically.
Fibre diameter did not vary between porosity classifications (p=0.95) but heparinized fi-
bres were significantly thicker on average than their unheparinized counterparts (3.6±0.2µm
vs 1.8±0.1µm, p<0.0001). Similarly, fibre alignment was not significantly influenced by
fibre fraction (p=0.7) but the heparinized groups exhibited a lesser degree of anisotropy
than unheparinized groups (0.07±0.02 vs 0.33±0.04, p<0.0001).
Pore-size measurements were found to have a log-normal distribution (Figure 4.4.1c) and
thus were transformed onto a logarithmic axis (Figure 4.4.1d) prior to statistical analysis.
No statistical differences were found between Hep and non-Hep groups (p=0.67) but
significant increases were observed between low and medium (p<0.0001), low and high
(p<0.0001) but not medium and high (p=0.54) groups. Low, medium and high groups
had mean pore-sizes of 4.0±2.1µm, 9.6±4.2µm and 10.3±5.2µm, respectively.
The measured porosity values of low, medium and high classification scaffolds was 76%±0.2%,
83%±0.5% and 90%±1.0%, respectively (p<0.0001); no statistical differences were de-
tected in porosity between Hep and non-Hep groups (p=0.27).
Scaffold thickness did not deviated significantly between porosity classifications before
implantation (p>0.1, n=12) and only a slight, non-significant, increase was observed
between non-heparinized and heparinized groups (0.09±0.04 mm, p=0.09), thus a mean
scaffold thickness of 1.0±0.05 mm was calculated.
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Figure 4.24: SEM images of scaffolds for in Vivo study: low, medium and high porosity
scaffolds with heparinized versions of each. Scale bars represent 50µm
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Figure 4.25: Morphological comparison of scaffold groups for implant: a) fibre diameter
(n=4 samples x 2 images per sample), b) fibre alignment (n=4), c)& d) Tukey box
& whiskers plots of pore-size and logarithm of pore-size (n=4 samples x 2 images per
sample), e) low-high plot of scaffold porosity (n=12) (*** denotes significance between
porosity classifications) and f) scaffold thickness (n=12). *, **, *** Denote statistical
significance between groups with p-values less than 0.05, 0.001 and 0.0001, respectively
(uncorrected multiple comparisons)
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4.4.1.1 NanoCT Scan
Low and high porosity scaffolds (non-heparinized) were scanned by NanoCT at a res-
olution of 500nm and rendered in 3D. The results of the scan, while not sufficient for
statistical analysis due to low sample size (n=1), are still interesting to compare to mor-
phological measures obtained through SEM image analysis and porosity values calculated
by the gravimetric method. Table 4.2 below summarises the results of each for compar-
ison and Figure 4.26 provides 3D and cross-sectional images of the resultant NanoCT
scans.
Table 4.2: Comparison of NanoCT Results to SEM Results
NanoCT SEM/Gravimetric
Measure Low High Low High
Porosity 59% 79% 76±0,2% 90±1,0%
Fibre Diameter 2,36µm 1,94µm 1,9±1,0µm 1,8±0,8µm
Pore-size 3,37µm 7,38µm 4,0±2,3µm 11,1±5,5µm
Anisotropy 0,28 0,23 0,34±0,06 0,29±0,09














Figure 4.26: NanoCT renders of low and high porosity classification scaffolds, note the
palpable difference in density. Scale bars represent 50µm
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4.4.2 Histological Analysis
Low, medium, high and heparinized versions of each were explanted at 7, 14 and 28 days
and compared for tissue ingrowth, collagen deposition, vascularisation and inflammatory
response within the scaffold boundaries.
Tissue ingrowth was observed to increase over implant duration (p<0.05) for all groups
but at different rates (low = 28±19 µm/week, medium = 60±14 µm/week, high = 155±23
µm/week, p=0.0002), where low, medium and high porosity scaffolds exhibited minimal
(33±1%), moderate (71±9%) and complete (96±4%) ingrowth by day 28 (p<0.001).
See Figure 4.28a and accompanying table for a complete statistical comparison of the
different groups and Figure 4.27 for representative H&E stained micrographs of each
porosity group over time.
No statistically significant differences were observed between heparinized and non-heparinized
groups in tissue ingrowth (Figure 4.29), collagen deposition, vascularisation or inflamma-
tory response (Figure 4.31 and Figure 4.32). Large differences were noted between poros-
ity classes for collagen deposition and vascularisation (presented individually below) but
not for inflammatory response where no significant differences were observed between
groups or time points (p>0.05).
Collagen deposition area was observed to increase over time (p<0.0001) and with increas-
ing porosity (p<0.0001) when measured as a fraction of the total scaffold area; however,
when adjusted for available ingrowth area (calculated from H&E sections) collagen de-
position per available ingrowth area was observed to be statistically independent of time
with all groups having similar slopes (p=0.52) but with high porosity groups having
higher elevations (p<0.001) than other groups. See Figure 4.28b&c.
Significantly more vascularisation was observed in high porosity scaffolds (27±12 vessels/mm2)
than low (2±3 vessels/mm2, p<0.0001) and medium (where vascularisation was only ob-
served after 28 days, 19±13 vessels/mm2, p=0.06) porosity scaffolds. See Figure 4.28d.
No significant differences were observed in inflammatory response between groups or
implant duration (p>0.5) where inflammatory response was measured as the area of ED1
tagged macrophages and foreign body giant cells (FBGC) per scaffold area. See Figure
4.28e.
High porosity scaffolds were observed to increase in thickness over time, starting at
243±43µm and 455±205µm at 7 days and ending at 881±307µm and 1290±357µm at
28 days for non-heparinized and heparinized versions, respectively; other groups did not
change significantly in thickness over time (p>0.07). All groups appeared thinner in
histological sections than measured before implantation with exception of high porosity
scaffolds. See Figure 4.30.
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Figure 4.27: H&E Results of low, medium and high classification scaffolds (non-heparinized) at 7, 14 and 28 days showing cellular and
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Figure 4.28: Summary of in Vivo results (n=6): a) linear regression analysis of groups
over implant time, b) linear regressions of collagen area over time, c) collagen area nor-
malised to tissue populated area (no significant differences between groups), d) density
of vessels (≥100µm2) per mm2, e) area of ED1 stained macrophages/FBGC per scaffold
area. *, **, *** Denote statistical significance between groups with p-values less than
0.05, 0.001 and 0.0001, respectively (Tukey corrected multiple comparisons). a: 7&14
days→n=2; 28 days→n=6
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Low Medium High
Non-Hep Hep Non-Hep Hep Non-Hep Hep
Figure 4.29: H&E stained micrographs of low, medium and high classification scaffolds
and their heparinized versions at 28 days post implantation, no noticeable differences in
tissue infiltration between heparinized and non-heparinized groups. Scale bars represent
500µm
Figure 4.30: Thickness measure-
ments from histological images
(H&E) were consistently smaller
than recorded before implant.
Low and medium class scaf-
folds did not undergo significant
changes over time but high type
scaffolds almost tripled in width.
*, **, *** Denote statistical
significance between groups with
p-values less than 0.05, 0.001
and 0.0001, respectively (Tukey
corrected multiple comparisons)
(n=6)
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Figure 4.31: Typical histological results of Picroserius red (PSR), CD31 and ED1 stains
for non-heparinized groups. PSR stains collagen red. CD31 stains endothelial cells purple.
ED1-Cy3 bound macrophage cells and FBGCs fluoresce red/orange, DAPI tagged nuclei
fluoresce blue. Scale bars represent 100µm
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Figure 4.32: Typical histological results of Picroserius red (PSR), CD31 and ED1 stains
for heparinized groups. PSR stains collagen red. CD31 stains endothelial cells purple.
ED1-Cy3 bound macrophage cells and FBGCs fluoresce red/orange, DAPI tagged nuclei
fluoresce blue. Scale bars represent 100µm
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Chapter 5
Discussion
This chapter will discuss in detail the results observed in Chapter 4 in the same order,
with the initial results obtained from single spinneret electrospinning (Section 5.1) being
covered first followed by a discussion of the various results obtained during dual elec-
trospinning in Section 5.2. A separate examination (Section 5.3) of the effects of the
heparinization process will be provided and finally the implications of the in Vivo study
(Section 5.4) will be discussed.
5.1 Single Spinneret Electrospinning
5.1.1 PU Fibre Optimization
PU fibres spun from THF:DMF co-solvent solutions were thinner, less aligned and were
deposited over a wider area of the collector (all other parameters held constant). The
observed reduction in fibre diameter when spinning from THF:DMF when compared to
THF can be attributed to an increase in net charge density, due to the higher dielectric
constant of the co-solvent mix, thereby increasing the tensile force on the solution yielding
thinner fibres [183,189]. These observations are in agreement with current literature where
both Wang et al (2013) and Feng et al (2013) concluded that PU solutions spun with
a co-solvent mix of THF:DMF (1:1) yielded the smaller diameter fibres with less defects
than when spinning from THF or DMF alone [190, 228]. The same mechanism can also
be used to explain why fibre alignment and deposition were affected by the THF:DMF
solvent system; the increased charge density of the solution causes increased repulsion
forces between adjacent segments of the fibrous jet, resulting in a pronounced whipping
effect, causing a larger radius for fibre deposition and more variation in fibre angle. These
effects are also well documented in literature [148,188,228].
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For the purposes of vascular grafts complete fibre alignment, as observed in PU/THF, is
not desirable due to the lack of strength in the transverse direction resulting in inability
to endure surgical handling and poor suture retention [127]. Additionally, as will be
discussed later in Section 5.2.4 a degree of fibre isotropy and a wide fibre deposition band
is desired for inter-dispersion with the sacrificial fibres.
5.1.2 PEO Fibre Diameter
Two distinctly different fibre diameter distributions were electrospun from the two sol-
vents, where PEO/DCM produced much larger fibres than PEO/EtOH for the flow rates
investigated. Interestingly, fibre diameter did not increase significantly with increasing
flow rate for PEO/EtOH as it did for PEO/DCM and as is commonly reported in lit-
erature [148, 182, 188]; however Son et al (2004), who spun PEO fibres from solvents of
Chloroform, EtOH, DMF and water, noted that flow rate did not have consistent effects
on fibre diameter across all solvents. It is a possibility that the effects of the flow rate on
fibre diameter are negated by the effects of the dielectric constant properties for the EtOH
solvent system, whereas for DCM, with much weaker dielectric properties, the effects of
the flow rate are more pronounced.
The overwhelming majority of work in electrospinning is focussed on controlling process
parameters to reduce fibre diameter, to either better mimic the ECM (tissue engineer-
ing/regenerative medicine) or to increase surface-area/volume ratio (filtration), thus no
established techniques for creating large diameter fibres have been published, in this au-
thor’s knowledge, to date. In an attempt to create large diameter fibres DCM was selected
as a solvent for its high vapour pressure and low dielectric constant which would allow
spinning at short working distances (shown to increase fibre diameter) to the collector and
reduce the tensile force acting to elongate the fibrous jet (reducing fibre diameter). While
large fibre diameters were produced they were not uniform and many small diameter jets
were observed to extrude perpendicularly to the large diameter fibres. This phenomenon,
first observed by Reneker et al (2000), was proposed by Yarin et al (2005) to be due
to static undulations in the fibrous jet resulting in adjacent segments repelling the lo-
cal peaks into smaller diameter fibres, branching away perpendicularly from the primary
jet [114, 181]. These anomalies are observed to be more common with large diameter fi-
bres being spun at electric field strengths well above the minimum required for producing
a Taylor cone [110]. While the large diameter fibres had morphological defects, they were
still sufficient for the purposes of this study as they occupied a sufficiently larger volume
per fibre than fibres spun from PEO/EtOH.
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5.2 Dual Electrospinning
5.2.1 Tailoring the Electric Field for Dual Electrospinning
Introducing a second jet to the electrospinning process creates new issues that need
to be addressed in order to effectively control the process. The most prominent side-
effect of the dual spinning process is the electrostatic interaction between the charged
polymer jets as they traverse towards the collector. By charging the two spinnerets with
opposing polarities an attractive force will result between the two fibrous jets as they
near the collector. In the case of the large diameter mandrel the fibres’ trajectories
are impeded by the positioning of the collector between them. However, for the small
diameter mandrel the electrostatic attraction force between the two jets caused them
to collide in mid-air or collect on the opposite spinneret, with little-to-no deposition
occurring on the collector. This has also been observed by Ekaputra et al (2008) who
noted that deposition efficiency decreased markedly with decreases in collector diameter
while co-electospraying/electrospinning with opposing polarity spinnerets [216]. For the
purposes of small diameter vascular grafts, with mandrels less than 6mm in diameter,
this is an unacceptable result and so like-polarity charged spinnerets were investigated.
When both spinnerets are charged with a positive polarity the resultant jets act to repel
one another. This is also an undesirable feature for this study as the sacrificial fibre and
structural fibre are required to inter-disperse for facilitation of homogeneous void space
creation (post sacrificial fibre removal). In an attempt to forcibly direct the deposition of
the two fibres in the middle of the mandrel (transverse axis) electrostatic shields (guides)
were erected in parallel on either side of the collector. This worked to improve the
inter-deposition of the two fibre types but simultaneously acted to reduce the elongation
forces acting on each solution at the capillary tip (towards the collector), requiring higher
electric field strengths to initiate a stable Taylor cone. For this purpose the collector was
charged with an opposing polarity to the spinnerets, instead of being grounded, thereby
increasing the net potential difference between the spinnerets and the collector, promoting
jet formation. However, the magnitude of the applied voltage to the collector was limited,
as high voltages (|>3 kV|) caused arcing to the mandrel’s electric motor.
5.2.2 Drying Process Post PEO Extraction
Lyophilization (freeze drying) was necessary for preserving the void volume left by the
sacrificial fibres post removal, especially for very low PU fibre fractions. This could be due
to PU’s low stiffness and hence its inability to resist the weight and surface tension forces
of the water in its liquid form (when vacuum dried), resulting in its collapse over the
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newly generated voids where the PEO fibres had been removed. In contrast, lyophiliza-
tion better preserved the void spaces created by the removal of the PEO fibres through
the process of sublimation. It is important to retain the scaffolds bulk volume whilst re-
moving the PEO fibres or else the void space obtained by removal of the sacrificial fibres
will be lost to collapse of the bulk structure of the scaffold. While not explicitly reported
in literature, sacrificial fibre authors utilizing a hydration step followed by vacuum drying
report instability of low fibre fraction (< 50%) constructs post PEO removal [71, 212].
However, studies that freeze dried constructs post PEO removal were able to facilitate
structural stability at lower fibre fractions [213, 215]. This is supported by the increas-
ing difference in bulk volume reduction between freeze dried samples and vacuum dried
samples as fibre fraction is decreased (Figure 4.6).
5.2.3 Porosity Determination
The equivalence of the two porosity determination techniques, in this case, indicates that
the density of electrospun PU remained unchanged from its bulk form. This result indi-
cates that no micro-porosity exists within the PU fibres which would otherwise implicate
negative effects on scaffold strength. An additional benefit of this result is that it negated
the need to use the more labour intensive densitometric method.
5.2.4 Thin vs Thick Sacrificial Fibres
Composite scaffolds of PU with two distinctly different types of sacrificial PEO fibres were
created, verified for inclusion and removal and then studied for their effects on porosity
and mechanical properties of the remaining scaffold. It was found that the inclusion and
subsequent removal of thin sacrificial fibres produced constructs with higher porosities
than those where thick sacrificial fibres had been included/removed. This section aims
to discuss the mechanisms behind the observed differences between the two groups by
discussing the effects on porosity and mechanical properties separately.
5.2.4.1 Effect on Porosity
Visualisation of the inter-dispersion of thick or thin sacrificial fibres was verified separately
by both SEM and confocal microscopy (with fluoroscein and rhodamine fluorescent dyes
added to PU and PEO). Visualisation of the removal of the sacrificial fibre by confocal
microscopy was confounded by the indiscriminate removal of both dyes during the PEO
removal process. However, complete PEO removal was confirmed by washing to constant
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mass, where the mass loss was also compared to the predicted mass loss as calculated by
equation 3.12, a technique that has also been used by Milleret et al (2011) [71].
Surface SEM images of PU constructs (with thin, thick or no sacrificial fibre types)
visualised before and after the PEO removal process showed that inclusion and subsequent
removal of sacrificial fibres produced lower density architectures, with noticeably larger
void spaces between PU fibres, than scaffolds produced by the standard electrospinning
technique (100% PU). Note that the fibre packing density of pure PU scaffolds was
unchanged after undergoing the PEO removal process indicating that the process itself
was not responsible for the observed increases in void volume. Counter-intuitively, thick
sacrificial fibres produced less void space between PU fibres than thin sacrificial fibres
(same fibre fraction, Figure 4.9). These observations were confirmed during the porosity
analysis of the scaffolds post PEO removal, where all groups (thin, thick and no sacrificial
fibres) were equivalent in porosity before PEO removal, but post removal those constructs
fabricated with thin sacrificial fibres possessed significantly higher porosities on average
than those with thick and no sacrificial fibres (Figure 4.12a).
Figure 4.12b, hints at a possible mechanism for the observed reduction in porosity created
by thick sacrificial fibres compared to thin sacrificial fibres: thick groups lost four-times
more bulk volume than thin groups post PEO removal, resulting a large proportion of the
potential void space created being lost to the collapsing or compacting of the PU fibres.
This is visualized in Figure 4.10 where thick groups showed large, flattened-out voids
in-between dense layers of PU, in contrast to the low density mesh observed from thin
groups. Three mechanisms behind the collapse of void space observed in thick groups
are offered: 1) PU fibres are not stiff enough to resist bending over the long distances
associated with the voids created by thick sacrificial fibres (during removal process); 2) the
high momentum associated with the thicker PEO fibres causes the hybrid mesh already
present on the collector to be compacted on impact, causing PU fibres to form compact
meshes in between PEO fibres; and 3) the productivity (fibres deposited per unit area per
unit time) difference between PEO/DCM and PU/THF:DMF causes spatially distinct
structural and sacrificial fibre populations. These mechanisms will now be discussed in
more detail.
The PEO removal process involves high energy mixing in water/EtOH solutions, resulting
in unavoidable hydrodynamic stresses acting on the PU fibres. In the case where there are
large gaps of support between dense layers of elastic PU fibres (caused by the removal of
large sacrificial fibres) the hydrodynamic forces may cause collapse of the PU sheets into
the void spaces created by PEO removal. For thin sacrificial fibres, the span distance
between adjacent fibres is not as large due to the diameter of both the sacrificial and
structural fibre being in the same order of scale, thus void spaces are preserved. The
collapse of the PU fibres into the newly created void spaces could also be due to residual
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stresses in the elastic PU fibres, which form as they deposit and bend around large
PEO fibres. When the large PEO fibres are removed the PU fibres are allowed to relax
and straighten, thereby reducing the volume of the newly created voids. Whether due
to external or internal stresses, the results of Figure 4.12b showed that scaffolds spun
with PEO/DCM as a sacrificial fibre lost significantly more of their bulk volume in
the extraction process than scaffolds spun with PEO/EtOH. Nam et al (2007), who
added large NaCl particles simultaneously while electrospinning PCL, found that washing
out the NaCl crystals caused large delaminations in their place [217], similar to the
delaminations caused by the large sacrificial fibres seen in Figure 4.10a and Figure 4.10d.
The second mechanism offered as explanation for the reduced void space observed in
thick groups is based on the premise that thicker jets have greater mass than thinner jets;
resulting in greater impact energy when colliding with the collector, thus compacting the
existing mesh. This effect would be even more pronounced in the case where complete
evaporation of the solvent had not occurred, resulting in an even higher energy impact
due to the weight of the solvent. However, it could be argued that the momentum
gained from increased mass is balanced by the reduction in fibre velocity due to the
lower Coulomb force as a result of the low dielectric constant of DCM when compared to
EtOH (thin fibres); however, Reneker et al 2000 observed that the axial velocity of a jet
undergoing large whipping instabilities actually slowed down, from 1.1 m/s to 0.8 m/s, as
it traversed towards the collector (the radial component of velocity increased as it neared
the collector) [114]. Thus, for PEO/EtOH, the high charge density leads to thinner fibres
with larger whipping radii, in turn reducing the impact energy on the collector when
compared to PEO/DCM. The relationship between jet velocity and solvent dielectric
constant/conductivity has not been studied in great detail in existing literature so more
work is needed to verify the assumptions of this mechanism.
Finally, the third mechanism is that a productivity mismatch occurs between PEO/DCM
and PU/THF:DMF where an order of magnitude more PU fibres are deposited in an area
per unit time than PEO fibres, thus dense sheets of PU are formed around scantly de-
posited, large PEO fibres. This is in contrast to the match in productivity between
PEO/EtOH and PU/THF:DMF where equivalent amounts of fibres are deposited in an
area simultaneously, leading to a homogeneous mixture of the two fibre types. Produc-
tivity has been shown to be dependant on solvent conductivity and dielectric constant
where solutions with high values of these properties (DMF and EtOH) are observed to
be more productive [183].
The observed differences in void space between scaffolds fabricated with PEO/EtOH and
PEO/DCM are more likely due to a combination of the three mechanisms described above,
where productivity mismatch between PEO/DCM and PU/THF:DMF causes dense lay-
ers of PU to be distributed over large, amorphous, scantly-distributed PEO fibres, which
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are subsequently compacted by layer-upon-layer of massive PEO jets. This is in sharp
contrast to the thin PEO fibres, which due to their matched productivity and fibre diam-
eter to the PU fibres, deposit in an interspersed manner with no observable laminations.
The deposition of partially evaporated thick fibres does confound the comparison of the
two groups, however, even if perfectly formed thick fibres were produced, the issue of
spatial separation of the two fibre type populations would still remain; where void spaces
cannot be created between two structural fibres if sacrificial fibre does not occupy the
space between them. It appears that in order to obtain interconnected void spaces inside
the scaffold structure the productivity of the two polymeric solutions should be matched
to ensure homogeneous interspersion of the two fibre types. Additionally, the whipping
radii of the two polymeric jets should be large enough so as to ensure that the two
polymers co-deposit simultaneously on the same area of the collector mandrel.
5.2.4.2 Effect on Mechanical Properties
Ultimate tensile stress (UTS), Young’s modulus and maximum elongation have been
studied for scaffolds produced from thick and thin sacrificial fibres over a range of fibre
fractions. This section will describe and compare the trends observed with regard to fibre
fraction both before and after sacrificial fibre removal.
Before PEO removal, thin and thick sacrificial fibre inclusion appears to have oppos-
ing effects on scaffold UTS, with a positive correlation observed for thin groups compared
to a negative correlation for thick groups (Figure 4.16). It is important to note that the
extrapolated y-intercept (UTS) of the fitted line (linear regression) through thick groups
was observed to be significantly higher than for thin groups, while the difference at a PU
fibre fraction of 55% was not; resulting in lines with large y-intercept differences progress-
ing towards a common y-value at high PU fibre fractions. This observation correlated
well with the observed trend in Figure 4.5, where it was observed that PEO/DCM (thick)
produced stronger scaffolds at higher flow rates than PEO/EtOH (thin); thus for low
PU fibre fraction scaffolds (where PEO flow rate is high) the strength provided by thick
(PEO/DCM) PEO fibres is much higher than for thin (PEO/EtOH). Soliman et al (2011)
also observed that micron-scale PCL fibres produced stronger scaffolds than nanometre-
scale fibres, showing the influence of fibre diameter on resultant scaffold strength [132].
Both thin and thick groups exhibited similar responses to PU fibre fraction increases
for scaffold stiffness (Young’s modulus) where low fibre fraction scaffolds displayed the
high stiffness values of PEO, while high fibre fraction scaffolds where PU fibres were in
majority were dependant on the less stiff PU fibres. Interestingly, thick sacrificial fibres
did not produce stiffer scaffolds than thin fibres (as was expected from Figure 4.5). Bel-
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lan et al (2005) have shown that electrospun PEO fibres have higher Young’s moduli
than solvent-cast films which they hypothesize is due to molecular reorientation during
the electrospinning process [240]. At high PEO flow rates (low PU fibre fractions), fi-
bre deposition was observed to be “dry” for thin PEO/EtOH (thin groups) but “wet”
for PEO/DCM (thick groups). Thus, according to Bellan’s theory complete reorienta-
tion would occur in only the thin PEO groups, as the thick groups did not evaporate
completely before deposition, creating a balance in stiffness between the two groups.
The almost two-fold increase in maximum elongation observed in thick sacrificial groups
when compared to thin groups can be explained by the different deposition patterns ob-
served in the two groups. Thick sacrificial fibre scaffolds were observed to be laminated,
with separate layers of PEO and PU fibres, thus when uni-axially extended the fibrous
layers would slide over each other, aligning themselves to the axis of the applied stress.
For thin sacrificial fibre scaffolds the two fibre types intermeshed with each other which
did not allow for the extent of reorganisation observed in thick sacrificial groups, resulting
in lower strains-to-failure than thick groups. This theory is further reinforced by the ob-
servation that no significant differences were observed in maximum elongation before and
after PEO removal for thick groups but large increases were observed for thin groups.
For thin groups, the intermeshed PEO fibres that restricted the reorganisation of PU
fibres were no longer present after PEO removal, resulting in higher attainable strains
to failure. However, for thick groups, the PEO fibres did not restrict the reorganisation
of the PU fibres in the first place, so PEO removal did not influence scaffold maximum
elongation. Note that no significant differences were observed in fibre diameter or align-
ment between thin and thick groups post PEO removal, so the observed differences in
maximum elongation could not be due to these factors (Figure 4.13).
After PEO removal, thin and thick groups exhibited similar increases in both UTS
and Young’s modulus values with increasing PU fibre fractions. The apparent superiority
in strength and stiffness of thick groups when compared on the fibre fraction scale appears
to be due to thin groups having higher porosities for a given fibre fraction; thus when
compared on the porosity scale both groups exhibit equivalent strength and stiffness
properties. This observation correlates well with the theory that thick groups create lower
porosity due to their more severe bulk volume reductions post PEO removal. Removal
of the PEO fibre causes large reductions in Young’s modulus of the scaffold, this is
expected as the stiffer PEO fibre is no longer present in the scaffold and only elastic
PU fibre remain. These observations agree with those of Baker et al (2008) and Ifkovits
et al (2010) who found that co-spun scaffolds inherited a proportion of the properties
of each polymer depending on scaffold fibre fraction, similar to the observations in this
text [212,213].
Chapter 5: Discussion 98
University of Cape Town Department of Biomedical Engineering
Correlation between the mechanical properties measured and scaffold porosity was con-
sistently stronger than the correlation between the same properties and fibre fraction.
This is due to the porosity value taking into account the bulk volume changes which
affect stress and strain calculations, whereas fibre fraction does not. For example, if a
20% fibre fraction scaffold was measured to undergo a large bulk volume reduction it
would also have a thinner cross section, appearing stronger (σ = F/A) but it would also
have a lower porosity (P = VV oids/Vbulk), thus it would appear stronger than other 20%
samples on the fibre fraction scale but would fit well with similar porosity scaffolds on
the porosity scale.
Large decreases in UTS and Young’s modulus but minor increases in maximum elongation
were observed between circumferentially and transversely oriented scaffolds, respectively
(Figure 4.15). This was expected due to the fibre alignment being prominently in the
circumferential direction due to collector rotational velocity. This is in accordance with
current literature [71,212,241].
5.2.4.3 Effect of Testing Conditions on PU Mechanical Properties
Immersion in PBS at 37◦C did not significantly influence the mechanical properties of
100% PU scaffolds when tested in the circumferential direction. In transversely ori-
ented samples, immersion resulted in slight increases in Young’s modulus and maximum
elongation. However, while the values obtained for Young’s modulus were statistically
significant, they were too small to be of clinical significance. The increase in maximum
elongation for immersed samples has also been observed by Dempsey et al (2014), where
they attributed the increases to reorganisation of hard domains in the PU structure [242].
However Dempsey’s study immersed samples for much longer periods (36 days and 12
months) and still does not explain why differences were observed in the transverse but
not circumferential directions, more testing is required to determine the mechanisms in-
volved. Studies of the effects of physiological conditions on the mechanical properties of
synthetic polymers in current literature are both sparse and dependant on the materi-
als used: e.g. Lee et al found that PCL/collagen blends were significantly weaker with
higher maximum elongations at break when tested immersed in PBS at 37◦C than dry
at RT [243]; whereas Thomas et al (2007) found that tensile strength was not affected
by the same testing conditions for polyglyconate(Maxon R©) and its blends with gelatin
and elastin but tensile modulus was affected (differently for each blend) [244]. Thus, it
can be concluded that effects of hydration and temperature on mechanical properties are
polymer specific and should be tested to allow for effective, application-specific design.
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5.2.4.4 Summary
Two distinct sacrificial fibre diameters were compared over a range of fibre fractions where
thin sacrificial fibres, which exhibit electrospinning properties more closely matched to
the properties of the structural fibre, were found to produce more porosity than thick
sacrificial fibres, where moderate to severe delamination and bulk volume loss reduced
porosity creation effectiveness. The mechanical properties of the PEO and PU composite
scaffolds retained the properties of each individual material depending on the proportion
(fibre fraction) of their inclusion. Post PEO removal, thin and thick sacrificial fibres were
found to have equivalent, predictable reductions in strength and stiffness of the scaffolds,
but laminations resulting from the inclusion and subsequent removal of thick sacrificial
fibres resulted in higher maximum elongations in thick groups when compared to thin
groups.
5.2.5 Fibre Fraction vs Scaffold Morphology
Scaffolds of PU co-spun with thin sacrificial fibres (PEO/EtOH) in low, medium and
high porosity classifications were further evaluated before testing in Vivo. Low, medium
and high classifications, fabricated by adjusting PEO flow rate to obtain fibre fractions of
100% (0ml/hr), 70% (1ml/hr) and 30%(6ml/hr), respectively. The observation of PEO
fibre diameter being independent of flow rate (Figure 4.3 (EtOH)) worked in favour of
producing scaffolds where the only variable varied by adjusting flow rate was fibre fraction.
The measured values of porosity for all groups (low = 76±0.2%, medium = 83±0.5% and
high = 90±1%) compared well with predicted values from the plotted linear regression
(low = 75%, medium = 81% and high = 88%) indicating Equation 3.12 combined with
the linear regression of fibre fraction vs porosity, as a useful tool for controlling porosity.
Average pore size was found to be significantly larger for sacrificial (medium/high) over
pure PU constructs (low), however no statistically significant differences were observed
between medium and high porosity scaffolds. This is a result of the distribution of
pore size (depicted in the Tukey box and whisker plot of Figure 4.25c) which is severely
positively skewed with the majority of small pores overwhelming any large pores present.
However, it can be seen that high porosity scaffolds have abundantly more “outliers”
or large pores than other groups, and while the average pore size stated is in fact the
average; it is the large “outliers” that will dominate functional differences between scaffold
groups, as they will provide the void-space for cellular infiltration and vascularisation. A
computational study with electrospun, sacrificial fibres by Baker et al (2008) showed that
only at very low fibre fractions (±10%) does the average pore-size start to shift towards
a normal-shaped distribution, with large average pore sizes [212].
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PU fibre diameter and alignment were shown to be unaffected by the sacrificial fibre
inclusion and removal process (Figure 4.25a and Figure 4.25b) which was in accordance
with similar studies in literature [212,213].
NanoCT scans (Figure 4.26) of the low and high porosity scaffolds depicts the 3D density
differences between the two. One must be cautious when drawing inferences from the
single sample size scanned, but it can be seen that the software found similar results to
those measured by SEM in terms of fibre diameter and anisotropy. However, the porosity
and pore size results differed quite drastically for high porosity samples and could be
due to a number of factors. For instance, the high porosity samples are very sensitive to
handling and may have been compressed slightly when mounting for analysis, the scan
section is also a very small portion (1mm3) of the total scaffold size; thus more samples
are required to be scanned before comparisons can be made between methods or groups.
That being said, these scans are still of interest and show great promise for assessing the
3D morphological features of electrospun scaffolds.
5.2.5.1 Effects of Fibre Fraction on Compliance and Burst Pressure
Theoretical compliance, when calculated from the tensile testing data, was found to de-
crease linearly with increasing fibre fractions as expected when considering the associated
increases in fibre density. Similarly, for the same reason, burst pressure was expected to
increase linearly with increasing fibre fractions, as was observed. This is the first study
that addresses compliance and burst pressure with scaffolds fabricated with sacrificial
fibres for controllable porosity and as a result it is difficult to verify these findings. How-
ever, while care has been taken to not oversimplify the assumptions in the calculations
(by using thick walled cylinder theory instead of thin walled), it is expected that cylindri-
cal constructs tested specifically for these properties will exhibit greater compliance and
lower burst pressure, due to un-modelled compression of the cylinder wall under radial
stress. That being said, the results calculated are useful for designing the next set of
experiments.
5.3 Heparin Surface Modification
PU scaffolds of various fibre fractions were successfully (covalently) grafted with heparin
and quantified for heparin content and for its effect on the mechanical properties of the
electrospun scaffold over a wide range of fibre fractions. Heparin content was found to be
constant over the range of fibre fractions when normalised to scaffold mass, which, with
constant average fibre diameter across fibre fractions (shown in Figure 4.25a), indicates
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that heparin content is dependant on the available PU surface area, where low fibre
fraction scaffolds have a lower total surface area than high fibre fraction scaffolds due
to lower fibre density. The normalised heparin content calculated in this study (7.5±0.7
mg/g) is 10× less than values obtained by Steffens et al (2004) of 68±3µg/mg for heparin
surface modified collagen matrices, however, their scaffolds had far greater surface-to-
volume ratios due to the smaller diameter of collagen fibres [245].
Whether the concentration of surface immobilized heparin is sufficient to make a physi-
ologically significant difference in blood clotting time and how long it will remain active
requires more research. A similar study by Ye et al (2011), where they immobilized hep-
arin on electrospun PCL fibrous scaffolds, had a concentration of 39.8µg/cm2 (note the
difference in units to those used in this study) [246]. They were able to show that this
resulted in a significant increase in clotting time (in an activated thromboplastin time
assay) with PCL controls clotting at 51.8±0.7s and PCL-Hep samples clotting at >300s.
A separate study by Begovac et al (2003) monitored the heparin activity of Gore-tex R©
grafts with Carmeda R© bioactive surface heparin immobilization and found that heparin
activity did not reduce significantly over 12 weeks of in vivo implant (canine model,
n=15) [94]. These questions require more in-depth investigation going forward.
The “cobblestone” appearance of the heparinized fibres when viewed under SEM was
expected due to the stringent dehydration requirements for SEM visualisation, causing
the heparin hydrogel layer to dimple. Figure 4.25a shows that the modification causes
an average increase in diameter of 1.8µm (0.9µm thick) which correlates well with the
previous study in this group which observed the surface modification thickness to be
approximately 2µm (viewed hydrated, in its swollen form, under environmental SEM)
[15]. However, the thickness of the heparin layer was not significant on the structural
scales of the foamed PU scaffolds but resulted in doubling the fibre diameter of these
electrospun PU fibres. Pore-size and porosity were not affected by the heparin surface
modification (Figure 4.25c), again correlating with previous studies; however, the process
of heparinization was found to severely affect fibre alignment, with reduced anisotropy
resulting from wave-like fibrous morphologies (Figure 4.24). The reduced anisotropy
is believed to be due to the heparinization process, which involved vigorous mixing in
monomer solutions, causing the elastic PU fibres to deform under the hydrodynamic
stresses.
In terms of mechanical properties, the heparinization process was observed to initially
stiffen (higher Young’s modulus) but eventually weaken (lower UTS) the PU scaffolds
when pulled until failure under tensile loading. This observation was made in the trans-
verse as well as the circumferential orientation, indicating that the process of hepariniza-
tion caused the weakening of the fibres or more likely the weakening of the bonds between
fibres. The increase in Young’s modulus is suspected to be due to the hydrogel layer serv-
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ing to thicken the fibre diameter, creating a larger surface area on average. The reduction
in maximum elongation is also suspected to be due to weakening of the PU structure due
to the various monomer solutions and high energy mixing in the heparinization process.
When this tensile testing data is transformed into compliance and burst pressure, the
results show that the reductions in strength and increases in stiffness give heparinized
constructs inferior burst pressure and compliance values, respectively, when compared
to their PU counter-parts. However, when compared to the compliance of the popliteal
artery (healthy patients 70 years old [102]) 60% fibre fraction, heparinized scaffolds
are suitably matched for compliance while retaining sufficient burst pressure to meet the
scientific standard of 2000mmHg [127,238,239].
5.4 In Vivo Subcutaneous Study
Porosity was shown to be a pivotal variable, strongly correlating with increased tissue
ingrowth, vascularisation and collagen deposition. The most prominent result was that
high porosity scaffolds allowed full ingrowth by day 14 compared with low porosity scaf-
folds where ingrowth barely penetrated the surface of the scaffold by day 28. This result
agrees with previous studies in literature suggesting that cells require sufficiently sized
pores to penetrate and populate the scaffold interior (in vivo: [67, 213, 215, 247] and in
vitro: [71, 207,216,219]).
Heparin modified groups showed no significant differences in tissue ingrowth, collagen
deposition, vascularisation or inflammation when compared to their unmodified counter-
parts. This result diverges from previous results in this group where heparin modified,
porous, foamed PU scaffolds showed significantly more vascularisation in Vivo than non-
heparinized versions [15]. However, the analysis of vascularisation in this study was
confounded by the similarity in morphological features and low colour-contrast between
CD31 stained microvessels and unstained PU fibres, causing a large degree of variation,
reducing experimental power.
Expected wound healing response (i.e. recruitment of tissue macrophage cells, neovascu-
larisation, collagen deposition, presence of foreign body giant cells and development of
a fibrous capsule) was observed to progress with time at similar rates between porosity
groups; but with different intensities, where high porosity scaffolds produced more vascu-
larisation and collagen deposition at day 7 than low porosity groups by day 28. A similar
observation was made by Bergmeister et al (2013) where high porosity PU scaffolds, fa-
cilitated by larger fibre diameters, showed increased collagen deposition when compared
to low porosity scaffolds [67]. This increase in collagen deposition is suspected to be
caused by the larger surface area exposed to host tissue as a result of the increased space
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for cellular infiltration [248, 249]. Thus a collagen capsule for low porosity scaffolds will
envelop the outer surfaces of the scaffold as a whole, while for high porosity scaffolds the
capsule is required to surround each individual fibre, leading to the observed increases
in collagen density. The increase in vascularisation observed with increased porosity is
believed to be due to the increased space for vessel ingrowth, where the tightly packed
fibres of low porosity scaffolds obstructed infiltration.
Another important observation was the apparent thickening of the high porosity scaffolds,
where all other groups seemed to have been compacted by surrounding tissue (Figure
4.30). In high porosity groups fibres are packed less densely than other groups (with
longer distances between inter-fibre connections) allowing cells to move individual, elastic
PU fibres to make room for their own migration, proliferation and tissue deposition.
This mechanism is suggested to be the cause of many similar observations where cellular
infiltration has occurred in scaffolds with average pore-sizes known to be too small for
penetration into more rigid scaffold types (foamed scaffolds) [67, 248, 250]. Thus, the
initially observed compression of the scaffold is reversed into swelling as host cells infiltrate
the loosely packed fibrous structure and begin to proliferate and form tissue.
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Chapter 6
Conclusions
Cellular ingrowth was observed to be directly correlated to pore-size and porosity, which
could be increased through the inclusion and removal of sacrificial fibres. The method
presented in this study allows for porosity to be controlled by varying the fibre fraction
of the sacrificial fibre through control of the sacrificial solution flow rate; furthermore,
the compliance of cylindrical conduits are predicted to increase with porosity but must
be balanced with associated decreases in burst pressure.
Different electric field configurations for the application of small diameter vascular grafts
were explored, but like-charged spinnerets with the aid of electrostatic shields and an
oppositely charged collector to help guide inter-deposition of the two fibres was the only
viable option.
Scaffolds that included thin (PEO/EtOH) and thick (PEO/DCM) sacrificial fibres were
compared and, counter-intuitively, it was found that thin fibres produced larger increases
in porosity, believed to be due to mismatches in electrospinning solution properties be-
tween PEO/DCM and PU/THF:DCM (the latter of which produced laminations rather
than interconnected pores).
Heparin was successfully grafted to the surface of the PU fibres and was found to have no
negative impact on porosity or pore size but effectively doubled the fibre diameter and
reduced local fibre alignment. When implanted in vivo, equivalent ingrowth, vascularisa-
tion and inflammatory response was observed between heparinized and non-heparinized
groups.
Interestingly, it was observed that cells were able to deform the loosely packed, high poros-
ity scaffolds to make space for their own infiltration, proliferation and ECM deposition,
a characteristic that helps to explain why ingrowth is observed in fibrillar scaffolds where
pore sizes are much smaller than those required of more rigid phase-inversion/porogen
extraction type scaffolds.
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Chapter 7
Recommendations
This work focussed on tailoring the dual electrospinning with sacrificial fibres technique
for small diameter graft applications, where incorporation of Pellethane as the structural
fibre was used for its model polyurethane properties. However, as with any study there
are many recommendations for similar studies looking to take this work further:
• Utilization of degradable elastomers (e.g. Degrapol R©) to allow for tissue remod-
elling in Vivo. However, care should be taken during the extraction process to
prevent hydrolytic degradation of the structural fibre.
• Utilization of a sacrificial fibre with biocompatible break-down products. This will
allow for implantation of the scaffold as spun without the need for prior removal of
the sacrificial fibre. Thus drugs could be loaded into the sacrificial fibre allowing
for burst/sustained release over the degradation time of the polymer.
• Charging the sacrificial solution with high voltage alternating current (AC). While
potentially dangerous, it has been shown that AC electrospinning produces neu-
trally charged fibrous jets, which offers a potential solution to the repulsion like-
charged jets exhibited in this study [131]. However, the same study has also shown
that AC electrospinning produces jets without whipping instabilities; the findings
in this study indicate that this will impede inter-dispersion of the structural and
sacrificial fibre thereby reducing porosity gains.
• Improving the manufacturable graft length. The current study was limited in the
conduit lengths it could produce, this could be improved in further studies by ex-
tending the translation distance. Productivity could be improved by fitting multiple
spinnerets of each type on each side, however, the repulsive forces between fibres
will need to be accounted for in the electric field design.
106
University of Cape Town Department of Biomedical Engineering
• Quantification of the anti-coagulation properties of the heparinized conduits in an
in vitro model. While scaffold heparin content was quantified in this study, the
effects of the bound layer on blood clotting time were not. This would be a useful
study to perform before proceeding to a circulatory model.
• Implantation of low, medium and high porosity grafts in a circulatory model. This
thesis has shown that high porosity scaffolds allow for rapid tissue ingrowth and
vascularisation whereas low porosity scaffolds prevented cellular penetration into
the inner networks of its fibrous mesh. The logical next step is to determine whether
the increased porosity will allow for transmural endothelialisation (which has been
shown previously by our group in foamed PU scaffolds [16]). Figure 7.1 depicts the
tool-set developed in this study which can be used to roughly predict the resultant
porosity, compliance and burst pressure values of an electrospun graft with a given
fibre fraction (manufactured by the method presented in this text). Note that some
parameters may need to be adjusted for the smaller diameter collector, e.g. higher
collector rotational speed in order to maintain surface velocity to achieve the same
degree of fibre alignment.
• The effect of the heparin surface modification in high porosity grafts on transmural
bleeding upon implantation needs to be investigated further. We have had some
experience with heparinized high porosity foamed PU grafts in a rat aortic model
and found that pre-clotting in situ managed to prevent bleeding but if necessary
the injection of degradable hydrogels into the scaffold wall could be investigated as
a method to prevent early bleeding.
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Figure 7.1: Porosity and mechanical properties can be optimized by varying the fibre
fraction of electrospun constructs. By varying the fibre fraction (through control of PEO
solution flow rate), the porosity and compliance of the resulting conduit can be predicted.
PA 30 and PA 70 are compliance values of the human popliteal artery measured in patients
at ages of 29±4 and 69±10 years of age, respectively [102]. Artery refers to the minimum
burst pressure of 2000mmHg commonly sought in literature, however this value should
be used with discretion [127,238,239].
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